WO2018074640A1 - Pharmaceutical composition, health functional food, and cosmetic composition for preventing or treating hair loss - Google Patents
Pharmaceutical composition, health functional food, and cosmetic composition for preventing or treating hair loss Download PDFInfo
- Publication number
- WO2018074640A1 WO2018074640A1 PCT/KR2016/011928 KR2016011928W WO2018074640A1 WO 2018074640 A1 WO2018074640 A1 WO 2018074640A1 KR 2016011928 W KR2016011928 W KR 2016011928W WO 2018074640 A1 WO2018074640 A1 WO 2018074640A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- extract
- hair loss
- green tea
- weight
- parts
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
Images
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/105—Plant extracts, their artificial duplicates or their derivatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/78—Saururaceae (Lizard's-tail family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/82—Theaceae (Tea family), e.g. camellia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q7/00—Preparations for affecting hair growth
Definitions
- the present invention relates to a pharmaceutical composition and nutraceutical for preventing or treating hair loss.
- Hair is one of the major parts of the body derived from the outer cell layer of the skin and is considered an appendage of the skin along with sebaceous glands, sweat glands and nails. Hair is also known as skin inducer because it derives from the skin during developmental growth. Hair is important for the overall appearance of the human body, and despite the fact that some medical treatments have been developed, many people suffer from hair loss or hair weakness.
- the causes of hair loss include excessive male hormone action, excessive sebaceous secretion, poor blood circulation, poor peroxide, bacteria, deterioration of scalp function, hypoglycemic collagen production, genetic factors, aging and stress. come.
- no clear cause for hair loss is known, and in recent years, the hair loss population is increasing due to changes in dietary life and social stress, and the age is also decreasing and the female hair loss population is increasing.
- Korean Patent No. 10-0800359 discloses a composition exhibiting hair loss prevention and hair growth promoting effect.
- An object of the present invention is to provide a pharmaceutical composition for preventing or treating hair loss derived from natural materials.
- An object of the present invention is to provide a health functional food for preventing or improving hair loss derived from natural materials.
- composition for the prevention or treatment of hair loss comprising 25 to 75 parts by weight of Japonica leaf extract and 25 to 75 parts by weight of green tea extract based on 100 parts by weight of the Echochocho extract.
- the Echochocho extract, Japonica extract and green tea extract are each independently extracted and mixed, pharmaceutical composition for the prevention or treatment of hair loss.
- the Echochocho extract, leaf extract and green tea extract is not fermented, the pharmaceutical composition for the prevention or treatment of hair loss.
- black bean extract, glutinous rice extract, kelp extract, cheongung extract, nasturtium extract, root extract and licorice extract further comprises one or more extracts selected from the group, the pharmaceutical composition for the prevention or treatment of hair loss.
- Health functional food for the prevention or improvement of hair loss comprising 25 to 75 parts by weight of the extract of Japonica leaves and 25 to 75 parts by weight of green tea extract with respect to 100 parts by weight of the fish extract.
- Echochocho extract, Japonica extract and green tea extract are each independently extracted and mixed, health functional food for the prevention or improvement of hair loss.
- the black bean extract, glutinous rice extract, kelp extract, cheongung extract, nasturtium extract, root extract and licorice extract further comprises one or more extracts selected from the group, hair loss prevention or functional food .
- Cosmetic composition for the prevention or improvement of hair loss comprising 25 to 75 parts by weight of the extract of Japonica leaf and 25 to 75 parts by weight of green tea extract with respect to 100 parts by weight of the Echochocho extract.
- the Echochocho extract, cotyledon extract and green tea extract are each independently extracted and mixed, cosmetic composition for the prevention or improvement of hair loss.
- black soybean extract, glutinous rice extract, kelp extract, cheongung extract, nasturtium extract, root extract and licorice extract further comprises one or more extracts selected from the group, cosmetic composition for preventing or improving hair loss.
- the pharmaceutical composition, nutraceutical and cosmetic composition for preventing or treating hair loss according to the present invention exhibit a very excellent hair loss prevention, improvement or treatment effect.
- Figure 2 shows the results of H & E staining of rat skin tissue.
- Figure 3 shows the expression of IGF-1 and TGF- ⁇ 1 in rat skin tissue.
- Figure 4 shows the amount of IGF-1 and TGF- ⁇ 1 expression in rat skin tissue.
- the present invention relates to a pharmaceutical composition, health functional food and cosmetic composition for the prevention or treatment of hair loss, including Echochocho extract, Japonica leaf extract and Green tea extract, 25-75% Japonica leaf extract based on 100 parts by weight of the Echochocho extract.
- a pharmaceutical composition, health functional food and cosmetic composition for the prevention or treatment of hair loss including Echochocho extract, Japonica leaf extract and Green tea extract, 25-75% Japonica leaf extract based on 100 parts by weight of the Echochocho extract.
- the pharmaceutical composition, health functional food and cosmetic composition for the prevention or treatment of hair loss which can exhibit a very good hair loss prevention, improvement or treatment effect .
- the pharmaceutical composition for preventing or treating hair loss according to the present invention includes Echochocho extract, Japonica leaf extract and Green tea extract, and 25-75 parts by weight of Japonica leaf extract and 25-75 parts by weight of green tea extract based on 100 parts by weight of Echochocho extract. Include.
- the leaflets are rich in minerals, vitamins B1, B2, B6, vitamin C, vitamin E, vitamin K and niacin, and are rich in calcium, potassium, iron, magnesium, zinc, and other alphalinolenes, which break down cholesterol in the body. It contains almost all of the coenzyme components needed by the human body.
- perylaldehyde and beta-carotene exhibit strong antibacterial and antioxidant activity, and when used together with fish herb, shows excellent synergistic effect on hair loss.
- Green tea is an evergreen tree or shrub belonging to theaceae.
- Polyphenols found in green tea are known as flavonols and catechins, and are known to have various effects such as antioxidant, anticancer, anti-inflammatory, and antibacterial effects, and promote hair growth and hair root strengthening.
- the hair loss prevention or treatment effect may be excellent.
- the extract may include 55-75% by weight of Japonica Leaf Extract and 55-75% by weight of Green Tea Extract, and more preferably It may be included as 60 to 75 parts by weight of the extract of Japonica leaves and 60 to 75 parts by weight of green tea extract based on 100 parts by weight of Eochocho extract.
- Echochocho extract, cotyledon extract and green tea extract may be included as 70 parts by weight of Japonica leaf extract and 70 parts by weight of green tea extract based on 100 parts by weight of Echocho extract.
- the extracts of the medicinal herbs may be prepared according to a conventional method of producing a plant extract, for example, by adding an extracting solvent to the flowers, leaves, branches, roots, berries or shells or pulverized products of the components of each plant.
- the extract may be prepared by adding a fractional solvent to the crude extract prepared by extraction with an extraction solvent.
- the extraction solvent may be at least one selected from the group consisting of water and an organic solvent.
- the organic solvent may be a polar solvent such as an alcohol having 1 to 5 carbon atoms, the alcohol dilution ethyl acetate or acetone and a nonpolar solvent of ether, chloroform, benzene, hexane or dichloromethane, or a mixed solvent thereof.
- the alcohol having 1 to 5 carbon atoms may be methanol, ethanol, propanol, butanol, isopropanol, and the like, but is not limited thereto.
- the alcohol dilution water may be one obtained by diluting the alcohol in water at 50 to 99.9% (v / v).
- Extraction solvent used to obtain the extract of the present invention is preferably at least one selected from the group consisting of water, alcohol having 1 to 5 carbon atoms, alcohol dilution water and mixtures thereof, more preferably water, 1 carbon atoms It may be any one selected from the group consisting of alcohols of 4 to 4 and mixtures thereof, and most preferably 30 to 99% aqueous ethanol or alcohol.
- the extraction process may be performed at 4 ° C. to 120 ° C., or 50 ° C. to 90 ° C., or 70 ° C. to 85 ° C., but is not limited thereto.
- the extraction time is not particularly limited, but may be 10 minutes to 12 hours, preferably 1 hour to 6 hours.
- specific extraction methods include cold extraction method, hot extraction method, thermal extraction method, ultrasonic extraction method, and the like, it is possible to use a conventional extraction device, ultrasonic grinding extractor or fractionator.
- the extract extracted with the solvent may be further subjected to the fractionation process with any one solvent selected from the group consisting of hexane, methylene chloride, acetone, ethyl acetate, ethyl ether, chloroform, water and mixtures thereof.
- Two or more solvents may be used in the fractionation, and each solvent extract may be prepared using sequentially or mixed according to the polarity of the solvent.
- the fractionation process may be performed at 4 ° C. to 120 ° C., or 50 ° C. to 90 ° C., or 70 ° C. to 85 ° C., but is not limited thereto.
- the prepared extract or the fraction obtained by performing the fractionation process can be filtered or concentrated or dried to remove the solvent, it can be carried out both filtration, concentration and drying.
- the filtration may be performed using a filter paper or a reduced pressure filter
- the concentration may be concentrated under reduced pressure using a reduced pressure concentrator, for example, a rotary evaporator
- the drying may be performed by, for example, a lyophilization method.
- Eochocho extract, cotyledon extract, and green tea extract may be each independently extracted and mixed.
- the medicinal herbs are independently extracted and then mixed may exhibit a better hair loss prevention and treatment effect than simultaneously extracting Echoseong, cotyledon and green tea together.
- Eoseongcho extract, cotyledon extract and green tea extract may be unfermented. Therefore, a problem in process control such as corruption may not occur, and the process may be simple to enable manufacturing in a short time.
- the pharmaceutical composition for preventing or treating hair loss may further include a Angelica extract, Salvia extract and Gardenia extract, but the content ratio is not limited, Angelica extract 50 compared to 100 parts by weight of Echochocho extract To 100 parts by weight, 25 to 75 parts by weight of Salvia extract and 15 to 50 parts by weight of gardenia extract.
- Dongguk is a word that takes the root of Shingamchae from one shot and improves the blood circulation of the scalp.
- Salvia is a medicinal herb made from the roots of Salvia miltiorrhiza Bunge (Korea and China). This helps with blood circulation, removes blood and relieves limb pain. Menstrual dysmenorrhea, menstrual pain, postpartum abdominal pain, bloody heart abdominal pain, bruises, etc. are treated. Heals mental fever, bullshit, annoyance, insomnia, skin rash, palpitations due to high fever. Pharmacological action has been reported to coronary dilatation, lower cholesterol, lower blood pressure, activate liver function, sedative anti-inflammatory, anticancer, antibacterial activity.
- Gardenia is a fruit of gardenia and related plants, including gardenin, pectin, tannin, crocin, gardenoside, geniposide, scandoside (scandoside) and other ingredients are known, the effect on the ginger, blood pressure lowering action has been known.
- the pharmaceutical composition for preventing or treating hair loss further comprises one or more extracts selected from the group consisting of black bean extract, glutinous rice extract, kelp extract, celery extract, nasturtium extract, brown root extract, and licorice extract. It may include.
- Each of the medicinal extracts may be extracted according to the method described above.
- Each of the medicinal extracts may further increase the effect of preventing or improving hair loss.
- compositions of the present invention can be used in the form of powders, granules, tablets, capsules, suspensions, emulsions, syrups, aerosols and the like, oral dosage forms, external preparations, suppositories, and sterile injectable solutions according to conventional methods.
- Carriers, excipients and diluents that may be included in the composition containing the extract of the present invention include lactose, dextrose, sucrose, sorbitol, mannitol, xylitol, erythritol, maltitol, starch, acacia rubber , Alginate, gelatin, calcium phosphate, calcium silicate, cellulose, methyl cellulose, microcrystalline cellulose, polyvinyl pyrrolidone, water, methylhydroxybenzoate, propylhydroxybenzoate, talc, magnesium stearate and mineral oil have.
- diluents or excipients such as fillers, extenders, binders, wetting agents, disintegrating agents, and surfactants are usually used.
- Solid form preparations for oral administration include tablets, pills, powders, granules, capsules, and the like, which form at least one excipient such as starch, calcium carbonate, sucrose or lactose in the compound. Mixed with gelatin.
- excipients such as starch, calcium carbonate, sucrose or lactose in the compound.
- lubricants such as magnesium stearate and talc are also used.
- Oral liquid preparations include suspensions, solvents, emulsions, and syrups, and may include various excipients, such as wetting agents, sweeteners, fragrances, and preservatives, in addition to commonly used simple diluents such as water and liquid paraffin. .
- Formulations for parenteral administration include sterile aqueous solutions, non-aqueous solvents, suspensions, emulsions, lyophilized preparations, suppositories.
- non-aqueous solvent and suspending agent propylene glycol, polyethylene glycol, vegetable oil such as olive oil, injectable ester such as ethyl oleate and the like can be used.
- base of the suppository witepsol, macrogol, tween 61, cacao butter, laurin butter, glycerogelatin and the like can be used.
- the amount of the pharmaceutical composition of the present invention may vary depending on the age, sex, and weight of the patient, but may be 0.1 to 100 mg / kg, preferably 1 to 10 mg / kg once or several times daily.
- the dosage may also be increased or decreased depending on the route of administration, the severity of the disease, sex, weight, age, and the like. Therefore, the above dosage does not limit the scope of the present invention in any aspect.
- the pharmaceutical composition of the present invention can be used for female hair loss, circular hair loss, such as O-shaped hair loss, M-shaped hair loss, OM complex hair loss, lateral hair loss, hereditary hair loss, male hair loss, diffuse hair loss in which the hair at the crown area becomes thinner and thinner, and the like. It can be used for various hair loss symptoms.
- Health functional foods for preventing or improving hair loss according to the present invention includes Echochocho extract, Japonica leaf extract and Green tea extract, 25-75 parts by weight of Japonica leaf extract and 25-75 parts by weight of green tea extract based on 100 parts by weight of Echochocho extract Include.
- Each extract may be one extracted according to the method described above.
- the mixing ratio of Echochocho extract, Japonica extract and Green Tea extract is within the above range, it may be excellent in preventing hair loss or improving effect.
- the extract may include 55 to 75% by weight of Japonica Leaf Extract and 55 to 75% by weight of Green Tea Extract, and more preferably, 100 parts by weight of Echochocho extract. It may be included as 60 to 75 parts by weight of the extract of Japonica leaves and 60 to 75 parts by weight of green tea extract based on 100 parts by weight of Eochocho extract.
- Echochocho extract, cotyledon extract and green tea extract may be included as 70 parts by weight of Japonica leaf extract and 70 parts by weight of green tea extract based on 100 parts by weight of Echocho extract.
- Eochocho extract, cotyledon extract, and green tea extract may be each independently extracted and mixed.
- the medicinal herbs are independently extracted and then mixed may exhibit a better hair loss prevention and improvement effect than simultaneously extracting Echoseong, cotyledon and green tea together.
- Eoseongcho extract, cotyledon extract and green tea extract may be unfermented. Therefore, a problem in process control such as corruption may not occur, and the process may be simple to enable manufacturing in a short time.
- the health functional food for preventing or improving hair loss may further include a Angelica extract, Salvia extract and Gardenia extract, the content ratio is not limited, Angelica per 100 parts by weight extract It may be 50 to 100 parts by weight of the extract, 25 to 75 parts by weight of Salvia extract and 15 to 50 parts by weight of gardenia extract.
- it may further include one or more extracts selected from the group consisting of black soybean extract, glutinous rice extract, kelp extract, cheongung extract, nasturtium extract, brown root extract and licorice extract.
- Each of the medicinal extracts may be extracted according to the method described above.
- Each of the medicinal extracts may further increase the effect of preventing or improving hair loss.
- Health functional food of the present invention is a beverage containing the extract (including alcoholic beverages), fruits and processed foods thereof (e.g. canned fruit, canned food, jam, marmalade, etc.), fish, meat and processed foods thereof (e.g. Hams, sausage corn, etc.), breads and noodles (e.g. udon, soba noodles, ramen noodles, spaghetti, macaroni, etc.), fruit juices, various drinks, cookies, syrups, dairy products (e.g. butter, cheese, etc.), edible vegetable oils, Margarine, vegetable protein, retort food, frozen food, various seasonings (eg, miso, soy sauce, sauce, etc.).
- fruits and processed foods thereof e.g. canned fruit, canned food, jam, marmalade, etc.
- fish e.g. Hams, sausage corn, etc.
- breads and noodles e.g. udon, soba noodles, ramen noodles, spaghetti, macaroni, etc.
- fruit juices e.g.
- the health functional food of the present invention may be formulated into tablets, pills, powders, granules, powders, capsules, liquid formulations and the like. These may be formulated further comprising one or more of carriers, diluents, excipients and additives.
- additives that may be further included in the present invention, natural carbohydrates, flavors, nutrients, vitamins, minerals (electrolytes), flavors (synthetic flavors, natural flavors, etc.), colorants, fillers (cheese, chocolate, etc.), facts Acids and salts thereof, alginic acid and salts thereof, organic acids, protective colloidal thickeners, pH adjusting agents, stabilizers, preservatives, antioxidants, glycerin, alcohols, carbonating agents and flesh may be used.
- natural carbohydrates examples include monosaccharides such as glucose, fructose and the like; Disaccharides such as maltose, sucrose and the like; And conventional sugars such as polysaccharides such as dextrin, cyclodextrin, and sugar alcohols such as xylitol, sorbitol, and erythritol.
- natural flavoring agents tauumatin, stevia extract (for example, rebaudioside A, glycyrrhizin, etc.) and synthetic flavoring agents (saccharin, aspartame, etc.) can be advantageously used.
- the health functional food of the present invention includes various nutrients, vitamins, minerals (electrolytes), flavors such as synthetic flavors and natural flavors, coloring and neutralizing agents (such as cheese and chocolate), pectic acid and salts thereof, alginic acid And salts thereof, organic acids, protective colloid thickeners, pH adjusters, stabilizers, preservatives, glycerin, alcohols, carbonation agents used in carbonated beverages, and the like.
- the health functional food of the present invention may contain flesh for preparing natural fruit juice and vegetable beverage. These components can be used independently or in combination.
- carrier examples include, but are not limited to, lactose, dextrose, sucrose, sorbitol, mannitol, erythritol, starch, acacia rubber, calcium phosphate, alginate, gelatin, calcium phosphate, calcium Silicates, microcrystalline cellulose, polyvinylpyrrolidone, cellulose, polyvinylpyrrolidone, methylcellulose, water, sugar syrup, methylcellulose, methyl hydroxy benzoate, propyl hydroxy benzoate, talc, magnesium stearate And at least one selected from the group consisting of mineral oils.
- the content of the health functional food of the present invention as an active ingredient in the above-described formulations can be appropriately adjusted according to the use form and purpose, user condition, type of symptom and the weight, etc., 0.001 to 99.9% by weight, based on the solid content weight, preferably May be 0.01 to 50% by weight, but is not limited thereto.
- the cosmetic composition for preventing or improving hair loss according to the present invention includes Echochocho extract, Japonica leaf extract and Green tea extract, 25-75 parts by weight of Japonica leaf extract and Green Tea extract 25-75 with respect to 100 parts by weight of the Echochocho extract It includes parts by weight.
- Each extract may be one extracted according to the method described above.
- the mixing ratio of Echochocho extract, Japonica extract and Green Tea extract is within the above range, it may be excellent in preventing hair loss or improving effect.
- the extract may include 55 to 75% by weight of Japonica Leaf Extract and 55 to 75% by weight of Green Tea Extract, and more preferably, 100 parts by weight of Echochocho extract. It may be included as 60 to 75 parts by weight of the extract of Japonica leaves and 60 to 75 parts by weight of green tea extract based on 100 parts by weight of Eochocho extract.
- Echochocho extract, cotyledon extract and green tea extract may be included as 70 parts by weight of Japonica leaf extract and 70 parts by weight of green tea extract based on 100 parts by weight of Echocho extract.
- Eochocho extract, cotyledon extract, and green tea extract may be each independently extracted and mixed.
- the medicinal herbs are independently extracted and then mixed may exhibit a better hair loss prevention and improvement effect than simultaneously extracting Echoseong, cotyledon and green tea together.
- Eoseongcho extract, cotyledon extract and green tea extract may be unfermented. Therefore, a problem in process control such as corruption may not occur, and the process may be simple to enable manufacturing in a short time.
- the cosmetic composition for preventing or improving hair loss may further include a Angelica extract, Salvia extract and Gardenia extract, the content ratio is not limited, Angelica extract 50 compared to 100 parts by weight Eochocho extract To 100 parts by weight, 25 to 75 parts by weight of Salvia extract and 15 to 50 parts by weight of gardenia extract.
- the cosmetic composition for preventing or improving hair loss is more than one extract selected from the group consisting of black soybean extract, glutinous rice extract, kelp extract, cheongung extract, nasturtium extract, brown root extract, licorice extract It may include.
- Each of the medicinal extracts may be extracted according to the method described above.
- Each of the medicinal extracts may further increase the effect of preventing or improving hair loss.
- the cosmetic composition of the present invention may further include a composition selected from the group consisting of water-soluble vitamins, oil-soluble vitamins, polymer peptides, polymer polysaccharides, sphingolipids, and seaweed extracts.
- the water-soluble vitamin may be any compound that can be incorporated into cosmetics, but preferably vitamin B1, vitamin B2, vitamin B6, pyridoxine, pyridoxine, vitamin B12, pantothenic acid, nicotinic acid, nicotinic acid amide, folic acid, vitamin C, vitamin H, and the like. And salts thereof (thiamine hydrochloride, sodium ascorbate salt, etc.) and derivatives (ascorbic acid-2-sodium phosphate salt, ascorbic acid-2-magnesium phosphate salt, etc.) can also be used in the present invention. Included in The water-soluble vitamins can be obtained by conventional methods such as microbial transformation, purification from microorganism culture, enzyme or chemical synthesis.
- the oil-soluble vitamin may be any compound that can be formulated in cosmetics, but preferably vitamin A, carotene, vitamin D2, vitamin D3, vitamin E (d1-alpha tocopherol, d-alpha tocopherol, d-alpha tocopherol) and the like.
- Derivatives thereof ascorbic palmitate, ascorbic stearate, ascorbic acid dipalmitate, dl-alpha tocopherol acetate, dl-alpha tocopherolvitamin E, DL-pantothenyl alcohol, D-pantothenyl alcohol, pantothenyl) Ethyl ether
- Oil-soluble vitamins can be obtained by conventional methods such as microbial transformation, purification of microorganism culture, enzyme or chemical synthesis.
- the polymer peptide may be any compound as long as it can be incorporated into cosmetics.
- collagen, hydrolyzed collagen, gelatin, elastin, hydrolyzed elastin, keratin and the like can be given.
- Polymeric peptides can be purified and obtained by conventional methods such as purification from microbial cultures, enzymatic methods or chemical synthesis methods, or can be purified and used from natural products such as dermis and pig silk such as pigs and cattle.
- the polymer polysaccharide may be any compound as long as it can be incorporated into cosmetics.
- hydroxyethyl cellulose, xanthan gum, sodium hyaluronate, chondroitin sulfate or a salt thereof (sodium salt, etc.) may be mentioned.
- chondroitin sulfate or its salt, etc. can be normally purified from a mammal or fish.
- the sphingolipid may be any compound as long as it can be incorporated into cosmetics.
- ceramide, phytosphingosine, sphingosaccharide lipid and the like can be given.
- Sphingo lipids can usually be purified from mammals, fish, shellfish, yeasts or plants by conventional methods or obtained by chemical synthesis.
- the seaweed extract may be any compound as long as it can be blended into cosmetics.
- the seaweed extract may include brown algae extract, red algae extract, green algae extract, and the like.
- calginine, arginic acid, sodium arginate, Potassium arginate and the like are also included in the seaweed extract used in the present invention.
- Seaweed extract can be obtained by purification from seaweed by conventional methods.
- the cosmetic composition of the present invention may further include other components which are usually formulated into cosmetics as necessary in addition to the essential components.
- Ingredients that can be formulated include fats and oils, moisturizers, emollients, surfactants, organic and inorganic pigments, organic powders, UV absorbers, preservatives, fungicides, antioxidants, plant extracts, pH adjusters, alcohols, pigments, fragrances, and blood circulation accelerators. , A cooling agent, a restriction
- Examples of the fat or oil component include ester fats, hydrocarbon fats, silicone fats, fluorine fats, animal fats, and vegetable fats and oils.
- ester fats and oils As ester fats and oils, glyceryl tri2-ethylhexanoate, cetyl 2-ethylhexanoate, isopropyl myristate, butyl mystinate, isopropyl palmitate, ethyl stearate, octyl palmitate, isocetyl isostearate, stearic acid Butyl acid, ethyl linoleate, isopropyl linoleate, ethyl oleate, isocetyl acid isocetyl, isostyl acid isostearyl, isostaryl palmitate, octylate acid octylate dodecyl, isostearic acid isetyl, diethyl sebacinate, adidi Diisopropyl phosphate, isoalkyl neopentane, tri (capryl, capric acid) glyceryl
- Hydrocarbon-based oils such as squalene, liquid paraffin, alpha-olefin oligomer, isoparaffin, ceresin, paraffin, liquid isoparaffin, polybutene, microcrystal wax, and petrolatum, are mentioned as hydrocarbon-based oils and fats.
- silicone-based fats and oils polymethylsilicone, methylphenylsilicone, methylcyclopolysiloxane, octamethylpolysiloxane, decamethylpolysiloxane, dodecamethylcyclosiloxane, dimethylsiloxane, methylcetyloxysiloxane copolymer, dimethylsiloxane and methylsteoxysiloxane copolymer, Alkyl modified silicone oil, amino modified silicone oil, etc. are mentioned.
- Perfluoro polyether etc. are mentioned as fluorine-based fats and oils.
- Animal or vegetable fats and oils include avocado oil, almond oil, olive oil, sesame oil, rice bran oil, soybean oil, soybean oil, corn oil, rapeseed oil, almond oil, palm kernel oil, palm oil, castor oil, sunflower oil, grapes. Seed oil, Cottonseed oil, Palm oil, Cuckoo nut oil, Wheat germ oil, Rice germ oil, Shea butter, Walnut colostrum, Marker demia nut oil, Meadow home oil, Egg yolk oil, Uji, Horse oil, Mink oil, Orange rape oil, Jojoba Animal or vegetable fats and oils, such as oil, candler wax, carnava wax, liquid lanolin, hardened castor oil, etc. are mentioned.
- the moisturizing agent examples include a water-soluble low molecular moisturizer, a fat-soluble molecular moisturizer, a water-soluble polymer, and a fat-soluble polymer.
- fat-soluble low molecular humectants examples include cholesterol and cholesterol esters.
- water-soluble polymer carboxyvinyl polymer, polyasparaginate, tragacanth, xanthan gum, methyl cellulose, hydroxymethyl cellulose, hydroxyethyl cellulose, hydroxypropyl cellulose, carboxymethyl cellulose, water soluble chitin, chitosan, dextrin, etc. Can be mentioned.
- fat-soluble polymers examples include polyvinylpyrrolidone-eicosene copolymers, polyvinylpyrrolidone-hexadecene copolymers, nitrocellulose, dextrin fatty acid esters, polymer silicones, and the like.
- emollient agent examples include long-chain acyl glutamic acid cholesteryl ester, hydroxy stearic acid cholesterol, 12-hydroxystearic acid, stearic acid, rosin acid, lanolin fatty acid cholesteryl ester, and the like.
- nonionic surfactant nonionic surfactant, anionic surfactant, cationic surfactant, an amphoteric surfactant, etc. are mentioned.
- Nonionic surfactants include self-emulsifying glycerin monostearate, propylene glycol fatty acid esters, glycerin fatty acid esters, polyglycerol fatty acid esters, sorbitan fatty acid esters, POE (polyoxyethylene) sorbitan fatty acid esters, POE sorbitan fatty acid esters, POE glycerin fatty acid ester, POE alkyl ether, POE fatty acid ester, POE hardened castor oil, POE castor oil, POE / POP (polyoxyethylene / polyoxypropylene) copolymer, POE / POP alkyl ether, polyether modified silicone, laurin Acid alkanolamide, alkylamine oxide, hydrogenated soybean phospholipid, etc. are mentioned.
- Anionic surfactants include fatty acid soaps, alpha-acyl sulfonates, alkyl sulfonates, alkyl allyl sulfonates, alkyl naphthalene sulfonates, alkyl sulfates, POE alkyl ether sulfates, alkylamide sulfates, alkyl phosphates, POE alkyl phosphorus salts, alkyls Amide phosphate, alkyloylalkyl taurine salt, N-acylamino acid salt, POE alkyl ether carboxylate, alkyl sulfosuccinate salt, sodium alkyl sulfo acetate, acylated hydrolyzed collagen peptide salt, perfluoroalkyl phosphate ester, etc. Can be.
- Cationic surfactants include alkyltrimethylammonium chloride, stearyltrimethylammonium chloride, stearyltrimethylammonium chloride, cetostearyltrimethylammonium chloride, distearyldimethylammonium chloride, stearyldimethylbenzylammonium, behenyltrimethylammonium bromide, Benzalkonium chloride, diethylaminoethyl stearate, dimethylaminopropyl stearate, lanolin derivatives, quaternary ammonium salts, and the like.
- Amphoteric surfactants include carboxybetaine type, amidebetaine type, sulfobetaine type, hydroxysulfobetaine type, amide sulfobetaine type, phosphobetaine type, aminocarboxylate type, imidazoline derivative type, amideamine type and the like. Amphoteric surfactants; and the like.
- Organic and inorganic pigments include silicic acid, silicic anhydride, magnesium silicate, talc, sericite, mica, kaolin, bengal, clay, bentonite, titanium film mica, bismuth oxychloride, zirconium oxide, magnesium oxide, zinc oxide, titanium oxide, and oxide
- Inorganic pigments such as aluminum, calcium sulfate, barium sulfate, magnesium sulfate, calcium carbonate, magnesium carbonate, iron oxide, ultramarine, chromium oxide, chromium hydroxide, coloramine and composites thereof; Polyamide, polyester, polypropylene, polystyrene, polyurethane, vinyl resin, urea resin, phenol resin, fluorine resin, silicon resin, acrylic resin, melamine resin, epoxy resin, polycarbonate resin, divinylbenzene, styrene copolymer, Organic pigments such as silk powder, cellulose, CI pigment yellow, CI pigment orange, and composite pigments of these inorganic
- organic powder examples include metal soaps such as calcium stearate; Alkyl phosphate metal salts such as zinc sodium cetyl acid, zinc lauryl acid and calcium laurate; Acylamino acid polyvalent metal salts such as N-lauroyl-beta-alanine calcium, N-lauroyl-beta-alanine zinc, and N-lauroylglycine calcium; Amide sulfonic acid polyvalent metal salts, such as N-lauroyl-taurine calcium and N-palmitoyl-taurine calcium; N-epsilon-lauroyl-L-lysine, N-epsilon-palmitolyzine, N-alpha-paratoylol nitin, N-alpha-lauroyl arginine, N-alpha-cured fatty acid acyl arginine Acyl basic amino acids; N-acylpolypeptides, such as N-lauroyl glycyl
- Examples of the ultraviolet absorber include paraaminobenzoic acid, ethyl paraaminobenzoate, amyl paraaminobenzoic acid, octyl paraaminobenzoate, ethylene glycol salicylate, phenyl salicylate, octyl salicylate, benzyl salicylate, butylphenyl salicylate, homomentyl salicylic acid, and cinnamic acid.
- the fungicides include hinokithiol, trichloric acid, trichlorohydroxydiphenyl ether, chlorhexidine gluconate, phenoxyethanol, resorcin, isopropylmethylphenol, azulene, salicylic acid, zinphylthione, benzalkonium chloride, Photosensitizer 301, mononitrourecosodium, undecylenic acid, and the like.
- antioxidants examples include butylhydroxyanisole, propyl gallic acid, and erythorbic acid.
- pH adjuster examples include citric acid, sodium citrate, malic acid, sodium malate, fmaric acid, sodium pmarate, succinic acid, sodium succinate, sodium hydroxide, sodium dihydrogen phosphate, and the like.
- alcohol As alcohol, higher alcohols, such as cetyl alcohol, are mentioned.
- the compounding component which may be added other than this is not limited to this, although any said component can be mix
- the cosmetic composition of the present invention may take the form of a solution, an emulsion, a viscous mixture, or the like.
- Components included in the cosmetic composition of the present invention as an active ingredient may include components commonly used in cosmetic compositions in addition to the medicinal extract, for example, conventional stabilizers, solubilizers, vitamins, pigments and flavorings Adjuvants and carriers.
- the cosmetic composition of the present invention may be prepared in any formulation commonly prepared in the art, and includes, for example, milky lotion, cream, lotion, pack, foundation, lotion, essence, hair cosmetic, and the like.
- the formulation of the present invention is a paste, cream or gel
- animal carriers vegetable fibers, waxes, paraffins, starches, tracantes, cellulose derivatives, polyethylene glycols, silicones, bentonites, silicas, talc or zinc oxide, etc.
- carrier components can be used as carrier components.
- lactose, talc, silica, aluminum hydroxide, calcium silicate or polyamide powder may be used, in particular in the case of a spray, additionally chlorofluorohydrocarbon, propane Propellant such as butane or dimethyl ether.
- a solvent, solvating or emulsifying agent is used as the carrier component, such as water, ethanol, isopropanol, ethyl carbonate, ethyl acetate, benzyl alcohol, benzyl benzoate, propylene glycol, 1 Fatty acid esters of, 3-butylglycol oil, glycerol aliphatic ester, polyethylene glycol or sorbitan.
- liquid carrier diluents such as water, ethanol or propylene glycol
- suspending agents such as ethoxylated isostearyl alcohol, polyoxyethylene sorbitol ester and polyoxyethylene sorbitan ester, microcrystalline Cellulose, aluminum metahydroxy, bentonite, agar or tracant and the like can be used.
- the carrier component is an aliphatic alcohol sulfate, an aliphatic alcohol ether sulfate, a sulfosuccinic acid monoester, an isethionate, an imidazolinium derivative, a methyltaurate, a sarcosinate, a fatty acid amide.
- Ether sulfates, alkylamidobetaines, aliphatic alcohols, fatty acid glycerides, fatty acid diethanolamides, vegetable oils, linolin derivatives or ethoxylated glycerol fatty acid esters and the like can be used.
- the cosmetic composition of the present invention is a hair tonic, hair conditioner, hair essence, hair lotion, hair nutrition lotion, hair shampoo, hair rinse, hair treatment, hair cream, hair nourishment cream, hair moisturizer cream, hair massage cream, hair wax, Hair aerosol, hair pack, hair nutrition pack, hair soap, hair cleansing foam, hair oil, hair drier, hair preservative, hair dye, hair wave agent, hair bleach, hair gel, hair glaze, hair dresser, hair lacquer, hair moisturizer It may be prepared as a cosmetic, such as a riser, hair mousse or hair spray, but is not limited thereto.
- the pharmaceutical composition of the present invention can be used for female hair loss, circular hair loss, such as O-shaped hair loss, M-shaped hair loss, OM complex hair loss, lateral hair loss, hereditary hair loss, male hair loss, diffuse hair loss in which the hair at the crown area becomes thinner and thinner, and the like. It can be used for various hair loss symptoms.
- the extract was mixed in the content ratio shown in Table 1 (mixed after extraction).
- Example 5 after extracting 1 g of eosungcho, 1 g of Japonica leaf, and 1 g of green tea at 86 ° C. for 3 hours in 15 ml of ethanol 30%, the mixture was dried at 3 ° C. at 15-25 ° C. and 50-60% relative humidity. It was fermented for months and prepared by mixing filtration concentrated and hot air dried or spray dried extracts.
- Example 6 In the case of Example 6, 2 g of vinegar, 1 g of ginseng leaf, 1 g of green tea were mixed with 60 ml of ethanol 30%, extracted at 86 ° C. for 3 hours, filtered, concentrated, hot air dried or spray dried to prepare an extract.
- Example 7 2 g of Eoseongcho, 1 g of Japonica and 1 g of green tea were mixed in 60 ml of ethanol 30%, and extracted at 86 ° C. for 3 hours, followed by temperature conditions of 15 to 25 ° C. and relative humidity of 50 to 60%. Fermented for 3 months in, filtered concentrated and hot air dried Or spray dried extract was prepared by mixing.
- Example 8 after extracting 1 g of eosungcho, 1 g of ginseng leaf, and 1 g of green tea at 86 ° C. for 3 hours in 15 ml of ethanol 30%, 3 at 15-25 ° C. and 50-60% relative humidity conditions It was fermented for months and prepared by mixing filtration concentrated and hot air dried or spray dried extracts.
- Example 9 2 g of Echoseongcho, 1 g of Japonica, and 1 g of green tea were mixed in 60 ml of ethanol 30%, extracted at 86 ° C. for 3 hours, filtered, concentrated and hot air dried or spray dried to prepare an extract.
- Example 10 In the case of Example 10, 2 g of Echochocho, 1 g of Japonica, and 1 g of green tea were mixed in 60 ml of ethanol 30%, and extracted at 86 ° C. for 3 hours, followed by temperature conditions of 15 to 25 ° C. and relative humidity of 50 to 60%. It was fermented for 3 months in, prepared by mixing filtration concentrated and hot air dried or spray dried extract.
- Halogenated nucleotides such as the pyrimidine analog bromodeoxyuridine (BrdU) are useful for staining nascent (early) DNA in living cells or tissues.
- BrdU is used instead of thymidine in the replicating DNA in the "S" phase, when DNA in the nucleus is doubled in the cell cycle, and the amount of synthesized DNA is confirmed by staining with BrdU antibody. Can be.
- Table 3 shows the absorbance value according to the treatment concentration of the embodiment, the higher the absorbance means that the better the hair loss prevention, improvement or treatment effect.
- the MTT assay is a colorimetric assay that measures the absorption of a specific wavelength through color change.
- mitochondria reduce yellow soluble MTT tetrazolium to purple non-soluble MTT formazan (3- (4,5-dimethylthiazol-2-yl) -2,5-diphenyl-tetrazolium bromide).
- Table 4 shows the absorbance value according to the treatment concentration of the embodiment, the higher the absorbance means that the better the hair loss prevention, improvement or treatment effect.
- DHT Dihydrotestosterone
- 5- ⁇ -reductase in hair follicle cells is an enzyme that converts testosterone, a testosterone, into DHT, a more powerful metabolite, and has about 10 times stronger hormone activity than normal testosterone and acts on the hair roots to inhibit hair growth.
- mice C57BL / 6 mice are 6-7 weeks old and most of the hair is at rest and the skin color is pink. After adapting to the environment for about 7 days, it was used for the experiment.
- the hair was removed by using a hair clipper to prevent damage to the skin, and the animals were randomly divided into polycarbonate kennels and divided into groups.
- the defined natural product complexes in each group were administered orally for 4 weeks as doses.
- oral finasteride was administered at 0.5 mg / day (Hui-Wen Chiu et al. 2013). Oral administration was performed by a skilled investigator because of concerns about inflammation and damage in a way that is invasive to the esophagus (or airway). All animal experiments should be conducted in accordance with the guidelines of the Orthodontic Animal Experimentation Ethics Committee (2015-0198-01). Details of each group are as follows.
- IGF- 1 known as hair growth factor
- TGF - ⁇ 1 a hair growth inhibitory and hair loss-inducing factor
- lysis buffer 50 mM Tris-HCl, 120 mM NaCl, 2 nM EDTA, 1 mM EGTA, 1% Triton X-100 200ul was added, pulverized using a Homogenizer (Tissue tearor, Biospec, Korea), centrifuged, and the protein was quantified using Lowly method.
- Prosca and test substance were orally administered 1 day after hair removal. Almost no hair grew until 5 days after administration in all experimental groups. The positive and test substance groups began to grow more hair than the negative comparisons after 15 days, and after 25 days, the hairs grew black and black in the groups except negative comparison groups. Table 5 shows the grades of each group which were observed by the naked eye.
- Example 3 200mg / kg and 400mg / kg increased the number and size of hair follicles significantly. It was. Normal group, growth phase, negative comparisons are at rest, positive comparisons induce hair follicle growth in growth phase, Example 3 200mg / kg group is shown to promote hair follicle growth in growth phase, Example 3 The 400 mg / kg group has also been shown to shorten the time for rapid hair follicle growth and hair regrowth in the growing phase.
- Test substances vary in dosage and appear to promote, promote hair growth and help hair growth.
- TGF- ⁇ 1 a hair loss-inducing factor
- Example 3 400mg / kg group was found to be lower TGF- ⁇ 1 than Example 3 200mg / kg group.
- the hair follicle growth and hair regrowth were shortened.
- IGF-1 and TGF- ⁇ 1 were measured 4 weeks after oral administration of test substance, and the expression level of IGF-1 was increased in 400 mg / kg of test substance Example 3 compared to the normal group, and IGF-1 in the negative comparison example. The expression was low and the expression of TGF- ⁇ 1 was high.
- TGF- ⁇ 1 which is frequently expressed in Catagen and Teolgen periods, was the most expressed in the negative comparison cases, and in the test substance group, the expression of TGF- ⁇ 1 was lowered, and the expression of IGF-1, a hair growth factor, was increased. It was confirmed that the effect of promoting hair growth by inducing factors that switch from the resting phase to the growth phase.
- Example 3 200mg / kg and Example 3 400mg / kg as a test substance has a significant difference in the effect according to the dose, Example 3 in the group treated with 400mg / kg hair follicle than 200mg / kg treated group
- the number of cells increased and the depth of hair follicles also increased.
- the composition according to the present invention may promote and promote hair follicle growth and help hair growth.
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Botany (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Engineering & Computer Science (AREA)
- Mycology (AREA)
- Chemical & Material Sciences (AREA)
- Epidemiology (AREA)
- Biotechnology (AREA)
- Microbiology (AREA)
- Medicinal Chemistry (AREA)
- Medical Informatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Alternative & Traditional Medicine (AREA)
- Dermatology (AREA)
- Nutrition Science (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- Birds (AREA)
- Cosmetics (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
Description
본 발명은 탈모의 예방 또는 치료용 의약 조성물 및 건강기능식품에 관한 것이다.The present invention relates to a pharmaceutical composition and nutraceutical for preventing or treating hair loss.
모발은 피부의 외세포층에서 유래한 신체 주요 부위 중 하나로서 피지선, 땀선 및 손발톱과 더불어 외피의 부속구조로 여겨진다. 모발은 또한 발생학적 성장동안 외피로부터 유래하기 때문에 외피 유도물로 알려져 있다. 모발은 인체의 전체 외양에 있어 중요하며, 몇가지 의학적 치료법이 개발되어 있음에도 불구하고 많은 사람들이 탈모 또는 모발 약화로 고생하고 있는 것이 현실이다.Hair is one of the major parts of the body derived from the outer cell layer of the skin and is considered an appendage of the skin along with sebaceous glands, sweat glands and nails. Hair is also known as skin inducer because it derives from the skin during developmental growth. Hair is important for the overall appearance of the human body, and despite the fact that some medical treatments have been developed, many people suffer from hair loss or hair weakness.
탈모의 원인으로는 남성호르몬 작용 과잉설, 피지분비 과잉설, 혈액순환 불량설, 과산화물, 세균 등에 의한 두피기능 저하설, 모유두에서의 콜라겐생성 저하설, 유전적 요인, 노화 및 스트레스 등이 논의되어 왔다. 그러나 현재까지 탈모에 대한 명확한 원인은 밝혀져 있지 않은 상태이며 최근들어 식생활의 변화, 사회환경 등에 의한 스트레스 증가 등으로 탈모인구가 늘어나고 있고 그 연령 또한 낮아지고 있으며 여성 탈모 인구도 늘어나고 있는 실정이다.The causes of hair loss include excessive male hormone action, excessive sebaceous secretion, poor blood circulation, poor peroxide, bacteria, deterioration of scalp function, hypoglycemic collagen production, genetic factors, aging and stress. come. However, to date, no clear cause for hair loss is known, and in recent years, the hair loss population is increasing due to changes in dietary life and social stress, and the age is also decreasing and the female hair loss population is increasing.
종래에는 탈모를 치료 또는 예방하기 위해 혈행촉진, 모근기능강화, 두피보습의 방법 등이 있고, 상용화된 의약품으로는 남성호르몬 억제를 위한 여성호르몬을 주성분으로 한 제제나 혈압을 조절하는 고혈압 약이지만 복용하는 환자에게 털이 자라는 부작용에 착안해 개발된 미녹시딜 등이 판매되고 있으나 정력감퇴 등의 부작용 문제가 있고 사용을 중지할 경우 효과가 지속되지 못하고 사용 전 상태로 돌아간다는 단점이 있어 뚜렷한 효과를 지닌 것은 없는 실정이다.Conventionally, there are methods for promoting blood circulation, strengthening hair root function, and scalp moisturizing to treat or prevent hair loss, and commercially available medicines are mainly made of female hormones for suppressing male hormones or high blood pressure drugs that control blood pressure. Minoxidil, which is developed to focus on the side effects of hair growth, is sold to patients, but there are side effects such as loss of energy, and there is a disadvantage that if the use is stopped, the effect does not persist and returns to the state before use. It is true.
따라서 천연소재에서 유래하여 부작용이 없는 성분을 활용하여 탈모를 예방, 모발 성장 및 발모를 위한 치료방법 및 약학조성물에 대한 개발이 절실하다.Therefore, it is urgent to develop a therapeutic method and a pharmaceutical composition for preventing hair loss, hair growth and hair growth by using ingredients derived from natural materials and having no side effects.
한국등록특허 제10-0800359호에는 탈모방지 및 발모촉진효과를 나타내는 조성물이 개시되어 있다.Korean Patent No. 10-0800359 discloses a composition exhibiting hair loss prevention and hair growth promoting effect.
본 발명은 천연 소재 유래 탈모의 예방 또는 치료용 의약 조성물을 제공하는 것을 목적으로 한다.An object of the present invention is to provide a pharmaceutical composition for preventing or treating hair loss derived from natural materials.
본 발명은 천연 소재 유래 탈모의 예방 또는 개선용 건강기능식품을 제공하는 것을 목적으로 한다.An object of the present invention is to provide a health functional food for preventing or improving hair loss derived from natural materials.
1. 어성초 추출물, 자소엽 추출물 및 녹차 추출물을 포함하며,1. Containing Echo extract, leaf leaf extract and green tea extract,
상기 어성초 추출물 100중량부에 대하여 자소엽 추출물 25 내지 75중량부 및 녹차 추출물 25 내지 75중량부를 포함하는 탈모의 예방 또는 치료용 의약 조성물.Pharmaceutical composition for the prevention or treatment of hair loss comprising 25 to 75 parts by weight of Japonica leaf extract and 25 to 75 parts by weight of green tea extract based on 100 parts by weight of the Echochocho extract.
2. 위 1에 있어서, 상기 어성초 추출물, 자소엽 추출물 및 녹차 추출물은 각각 독립적으로 추출되어 혼합된 것인, 탈모의 예방 또는 치료용 의약 조성물.2. according to the above 1, the Echochocho extract, Japonica extract and green tea extract are each independently extracted and mixed, pharmaceutical composition for the prevention or treatment of hair loss.
3. 위 1에 있어서, 상기 어성초 추출물, 자소엽 추출물 및 녹차 추출물은 발효되지 않은 것인, 탈모의 예방 또는 치료용 의약 조성물.3. according to the above 1, the Echochocho extract, leaf extract and green tea extract is not fermented, the pharmaceutical composition for the prevention or treatment of hair loss.
4. 위 1에 있어서, 검정콩 추출물, 찹쌀 추출물, 다시마 추출물, 천궁 추출물, 한련초 추출물, 갈근 추출물 및 감초 추출물로 이루어진 군에서 선택된 1종 이상의 추출물을 더 포함하는, 탈모의 예방 또는 치료용 의약 조성물.4. according to the above 1, black bean extract, glutinous rice extract, kelp extract, cheongung extract, nasturtium extract, root extract and licorice extract further comprises one or more extracts selected from the group, the pharmaceutical composition for the prevention or treatment of hair loss.
5. 어성초 추출물, 자소엽 추출물 및 녹차 추출물을 포함하며,5. Includes Echo extract, Japonica extract and Green tea extract,
상기 어성초 추출물 100중량부에 대하여 자소엽 추출물 25 내지 75중량부 및 녹차 추출물 25 내지 75중량부를 포함하는 탈모의 예방 또는 개선용 건강기능식품.Health functional food for the prevention or improvement of hair loss comprising 25 to 75 parts by weight of the extract of Japonica leaves and 25 to 75 parts by weight of green tea extract with respect to 100 parts by weight of the fish extract.
6. 위 5에 있어서, 상기 어성초 추출물, 자소엽 추출물 및 녹차 추출물은 각각 독립적으로 추출되어 혼합된 것인, 탈모의 예방 또는 개선용 건강기능식품.6. In the above 5, the Echochocho extract, Japonica extract and green tea extract are each independently extracted and mixed, health functional food for the prevention or improvement of hair loss.
7. 위 5에 있어서, 상기 어성초 추출물, 자소엽 추출물 및 녹차 추출물은 발효되지 않은 것인, 탈모의 예방 또는 개선용 건강기능식품.7. In the above 5, wherein the Echochocho extract, leaf extract and green tea extract is not fermented, health functional food for the prevention or improvement of hair loss.
8. 위 5에 있어서, 검정콩 추출물, 찹쌀 추출물, 다시마 추출물, 천궁 추출물, 한련초 추출물, 갈근 추출물 및 감초 추출물로 이루어진 군에서 선택된 1종 이상의 추출물을 더 포함하는, 탈모의 예방 또는 개선용 건강기능식품.8. In the above 5, the black bean extract, glutinous rice extract, kelp extract, cheongung extract, nasturtium extract, root extract and licorice extract further comprises one or more extracts selected from the group, hair loss prevention or functional food .
9. 어성초 추출물, 자소엽 추출물 및 녹차 추출물을 포함하며,9. Includes Echo extract, Fructus leaf extract and Green tea extract,
상기 어성초 추출물 100중량부에 대하여 자소엽 추출물 25 내지 75중량부 및 녹차 추출물 25 내지 75중량부를 포함하는 탈모의 예방 또는 개선용 화장료 조성물.Cosmetic composition for the prevention or improvement of hair loss comprising 25 to 75 parts by weight of the extract of Japonica leaf and 25 to 75 parts by weight of green tea extract with respect to 100 parts by weight of the Echochocho extract.
10. 위 9에 있어서, 상기 어성초 추출물, 자소엽 추출물 및 녹차 추출물은 각각 독립적으로 추출되어 혼합된 것인, 탈모의 예방 또는 개선용 화장료 조성물.10. In the above 9, the Echochocho extract, cotyledon extract and green tea extract are each independently extracted and mixed, cosmetic composition for the prevention or improvement of hair loss.
11. 위 9에 있어서, 상기 어성초 추출물, 자소엽 추출물 및 녹차 추출물은 발효되지 않은 것인, 탈모의 예방 또는 개선용 화장료 조성물.11. In the above 9, wherein the Echochocho extract, leaf extract and green tea extract is not fermented, cosmetic composition for the prevention or improvement of hair loss.
12. 위 9에 있어서, 검정콩 추출물, 찹쌀 추출물, 다시마 추출물, 천궁 추출물, 한련초 추출물, 갈근 추출물 및 감초 추출물로 이루어진 군에서 선택된 1종 이상의 추출물을 더 포함하는, 탈모의 예방 또는 개선용 화장료 조성물.12. In the above 9, black soybean extract, glutinous rice extract, kelp extract, cheongung extract, nasturtium extract, root extract and licorice extract further comprises one or more extracts selected from the group, cosmetic composition for preventing or improving hair loss.
본 발명에 따른 탈모의 예방 또는 치료용 의약 조성물, 건강기능식품 및 화장료 조성물은 매우 우수한 탈모 예방, 개선 또는 치료 효과를 나타낸다.The pharmaceutical composition, nutraceutical and cosmetic composition for preventing or treating hair loss according to the present invention exhibit a very excellent hair loss prevention, improvement or treatment effect.
도 1은 쥐 모발의 상태를 육안으로 관찰한 결과를 나타낸 것이다.1 shows the results of visual observation of the state of rat hair.
도 2는 쥐 피부 조직의 H&E염색 결과를 나타낸 것이다.Figure 2 shows the results of H & E staining of rat skin tissue.
도 3은 쥐 피부 조직 내 IGF-1 및 TGF-β1 발현 여부를 나타낸 것이다.Figure 3 shows the expression of IGF-1 and TGF-β1 in rat skin tissue.
도 4는 쥐 피부 조직 내 IGF-1 및 TGF-β1 발현 양을 나타낸 것이다.Figure 4 shows the amount of IGF-1 and TGF-β1 expression in rat skin tissue.
본 발명은 탈모의 예방 또는 치료용 의약 조성물, 건강기능식품 및 화장료 조성물에 관한 것으로, 어성초 추출물, 자소엽 추출물 및 녹차 추출물을 포함하며, 상기 어성초 추출물 100중량부에 대하여 자소엽 추출물 25 내지 75중량부 및 녹차 추출물 25 내지 75중량부를 포함함으로써, 이들의 시너지 효과에 의해 매우 우수한 탈모 예방, 개선 또는 치료 효과를 나타낼 수 있는, 탈모의 예방 또는 치료용 의약 조성물, 건강기능식품 및 화장료 조성물에 관한 것이다.The present invention relates to a pharmaceutical composition, health functional food and cosmetic composition for the prevention or treatment of hair loss, including Echochocho extract, Japonica leaf extract and Green tea extract, 25-75% Japonica leaf extract based on 100 parts by weight of the Echochocho extract. By including 25 to 75 parts by weight of the green tea extract, and synergistic effects thereof, the pharmaceutical composition, health functional food and cosmetic composition for the prevention or treatment of hair loss, which can exhibit a very good hair loss prevention, improvement or treatment effect .
이하 본 발명을 상세히 설명한다.Hereinafter, the present invention will be described in detail.
본 발명에 따른 탈모의 예방 또는 치료용 의약 조성물은 어성초 추출물, 자소엽 추출물 및 녹차 추출물을 포함하며, 상기 어성초 추출물 100중량부에 대하여 자소엽 추출물 25 내지 75중량부 및 녹차 추출물 25 내지 75중량부를 포함한다.The pharmaceutical composition for preventing or treating hair loss according to the present invention includes Echochocho extract, Japonica leaf extract and Green tea extract, and 25-75 parts by weight of Japonica leaf extract and 25-75 parts by weight of green tea extract based on 100 parts by weight of Echochocho extract. Include.
*어성초는 항균, 항염 효과를 나타내어, 말라세지아, 포도상구균 등의 탈모균에 대한 항균 효과가 우수하다.* Fish herb has antibacterial and anti-inflammatory effect, and has excellent antibacterial effect against hair loss bacteria such as Malassezia and Staphylococcus.
자소엽은 미네랄, 비타민 B1, B2, B6, 비타민 C, 비타민 E, 비타민 K, 나이아신이 다량 함유되어 있고, 체내에 콜레스테롤을 분해하는 알파리놀렌을 비롯한 칼슘, 칼륨, 철분, 마그네슘, 아연 등이 풍부하여 인체에 필요한 코엔자임 성분이 거의 다 포함되어 있다. 또한, 페릴알데하이드, 베타카로틴은 강한 항균 작용 및 항산화 작용을 나타내어, 어성초와 함께 사용시에 탈모에 대한 우수한 시너지 효과를 나타낸다.The leaflets are rich in minerals, vitamins B1, B2, B6, vitamin C, vitamin E, vitamin K and niacin, and are rich in calcium, potassium, iron, magnesium, zinc, and other alphalinolenes, which break down cholesterol in the body. It contains almost all of the coenzyme components needed by the human body. In addition, perylaldehyde and beta-carotene exhibit strong antibacterial and antioxidant activity, and when used together with fish herb, shows excellent synergistic effect on hair loss.
녹차는 차나무과(Theaceae)에 속하는 상록 교목 또는 관목이다. 녹차에서 발견되는 폴리페놀 성분은 플라보놀과 카테킨 성분으로 알려져 있으며, 항산화, 항암, 항염증, 항균 등의 다양한 효능 효과를 가지고 있는 것으로 알려져 있어, 모발 성장 촉진, 모근 강화 등의 효과를 나타낸다.Green tea is an evergreen tree or shrub belonging to theaceae. Polyphenols found in green tea are known as flavonols and catechins, and are known to have various effects such as antioxidant, anticancer, anti-inflammatory, and antibacterial effects, and promote hair growth and hair root strengthening.
본 발명에 따라 어성초 추출물, 자소엽 추출물 및 녹차 추출물의 혼합비가 상기 범위 내인 경우 탈모 예방 또는 치료 효과가 우수하게 나타날 수 있다.According to the present invention, if the mixing ratio of Echochocho extract, Japonica leaf extract and green tea extract is within the above range, the hair loss prevention or treatment effect may be excellent.
또한, 어성초, 자소엽 및 녹차의 시너지 효과를 극대화 시키기 위한 측면에서 바람직하게는 어성초 추출물 100중량부에 대하여 자소엽 추출물 55 내지 75중량부 및 녹차 추출물 55 내지 75중량부로 포함될 수 있으며, 더욱 바람직하게는 어성초 추출물 100중량부에 대하여 자소엽 추출물 60 내지 75중량부 및 녹차 추출물 60 내지 75중량부로 포함될 수 있다. 예컨대, 어성초 추출물, 자소엽 추출물 및 녹차 추출물은 어성초 추출물 100중량부에 대하여 자소엽 추출물 70중량부 및 녹차 추출물 70중량부로 포함될 수 있다.In addition, in terms of maximizing the synergistic effect of Echochocho, Japonica and Green Tea, the extract may include 55-75% by weight of Japonica Leaf Extract and 55-75% by weight of Green Tea Extract, and more preferably It may be included as 60 to 75 parts by weight of the extract of Japonica leaves and 60 to 75 parts by weight of green tea extract based on 100 parts by weight of Eochocho extract. For example, Echochocho extract, cotyledon extract and green tea extract may be included as 70 parts by weight of Japonica leaf extract and 70 parts by weight of green tea extract based on 100 parts by weight of Echocho extract.
상기 약재들의 추출물은 통상의 식물 추출물의 제조방법에 따라 제조된 것일 수 있으며, 일 예로 각 식물의 구성 성분의 꽃, 잎, 가지, 뿌리, 열매 또는 껍질이나 이의 분쇄물에 추출용매를 가함으로써 제조하거나 추출용매로 추출하여 제조한 조추출물에 분획용매를 가하여 분획하여 제조된 것일 수 있다.The extracts of the medicinal herbs may be prepared according to a conventional method of producing a plant extract, for example, by adding an extracting solvent to the flowers, leaves, branches, roots, berries or shells or pulverized products of the components of each plant. Alternatively, the extract may be prepared by adding a fractional solvent to the crude extract prepared by extraction with an extraction solvent.
상기 추출용매는 물 및 유기용매로 이루어진 군에서 선택된 1종 이상일 수 있다. 상기 유기용매는 탄소수 1 내지 5의 알코올, 상기 알코올 희석수 에틸아세테이트 또는 아세톤 등의 극성용매와 에테르, 클로로포름, 벤젠, 헥산 또는 디클로로메탄의 비극성용매 또는 이들의 혼합용매일 수 있다. 상기 탄소수 1 내지 5의 알코올은 메탄올, 에탄올, 프로판올, 부탄올, 이소프로판올 등일 수 있으나, 이에 한정되는 것은 아니다. 또한, 알코올 희석수는 알콜을 50 내지 99.9%(v/v)로 물에 희석한 것일 수 있다.The extraction solvent may be at least one selected from the group consisting of water and an organic solvent. The organic solvent may be a polar solvent such as an alcohol having 1 to 5 carbon atoms, the alcohol dilution ethyl acetate or acetone and a nonpolar solvent of ether, chloroform, benzene, hexane or dichloromethane, or a mixed solvent thereof. The alcohol having 1 to 5 carbon atoms may be methanol, ethanol, propanol, butanol, isopropanol, and the like, but is not limited thereto. In addition, the alcohol dilution water may be one obtained by diluting the alcohol in water at 50 to 99.9% (v / v).
본 발명의 추출물을 얻기 위해 사용된 추출용매는 바람직하게는 물, 탄소수 1 내지 5의 알코올, 알코올 희석수 및 이들의 혼합물로 이루어진 군에서 선택된 1종 이상일 수 있고, 더욱 바람직하게는 물, 탄소수 1 내지 4의 알코올 및 이들의 혼합물로 이루어진 군에서 선택된 어느 하나일 수 있으며, 가장 바람직하게는 30 내지 99% 에탄올 수용액 또는 주정일 수 있다. 상기 추출과정은 일 예로, 4℃ 내지 120℃, 또는 50℃ 내지 90℃, 또는 70℃ 내지 85℃에서 수행될 수 있으나, 이에 한정되지는 않는다. 또한, 상기 추출시간은 특별히 한정되지는 않으나, 10분 내지 12시간, 바람직하게는 1시간 내지 6시간일 수 있다.Extraction solvent used to obtain the extract of the present invention is preferably at least one selected from the group consisting of water, alcohol having 1 to 5 carbon atoms, alcohol dilution water and mixtures thereof, more preferably water, 1 carbon atoms It may be any one selected from the group consisting of alcohols of 4 to 4 and mixtures thereof, and most preferably 30 to 99% aqueous ethanol or alcohol. For example, the extraction process may be performed at 4 ° C. to 120 ° C., or 50 ° C. to 90 ° C., or 70 ° C. to 85 ° C., but is not limited thereto. In addition, the extraction time is not particularly limited, but may be 10 minutes to 12 hours, preferably 1 hour to 6 hours.
또한, 구체적인 추출법으로 냉침추출법, 온침추출법, 열 추출법, 초음파 추출법 등을 들 수 있으며, 통상의 추출기기, 초음파분쇄 추출기 또는 분획기를 이용할 수 있다.In addition, specific extraction methods include cold extraction method, hot extraction method, thermal extraction method, ultrasonic extraction method, and the like, it is possible to use a conventional extraction device, ultrasonic grinding extractor or fractionator.
또한, 상기 용매로 추출한 추출물은 이후, 헥산, 메틸렌클로라이드, 아세톤, 에틸아세테이트, 에틸에테르, 클로로포름, 물 및 이들의 혼합물로 이루어진 군으로부터 선택된 어느 하나의 용매로 분획과정을 더욱 실시할 수 있다. 상기 분획 시 용매는 2종 이상 사용할 수 있으며, 용매의 극성에 따라 순차적으로 사용하거나 혼합하여 사용하여, 각 용매 추출물을 제조할 수 있다. 또한, 상기 분획과정은 일 예로, 4℃ 내지 120℃, 또는 50℃ 내지 90℃, 또는 70℃ 내지 85℃에서 수행될 수 있으나, 이에 한정되지는 않는다.In addition, the extract extracted with the solvent may be further subjected to the fractionation process with any one solvent selected from the group consisting of hexane, methylene chloride, acetone, ethyl acetate, ethyl ether, chloroform, water and mixtures thereof. Two or more solvents may be used in the fractionation, and each solvent extract may be prepared using sequentially or mixed according to the polarity of the solvent. In addition, the fractionation process may be performed at 4 ° C. to 120 ° C., or 50 ° C. to 90 ° C., or 70 ° C. to 85 ° C., but is not limited thereto.
상기 제조된 추출물 또는 상기 분획과정을 수행하여 수득한 분획물은 이후 여과하거나 농축 또는 건조과정을 수행하여 용매를 제거할 수 있으며, 여과, 농축 및 건조를 모두 수행할 수 있다. 구체적으로 상기 여과는 여과지를 이용하거나 감압여과기를 이용할 수 있으며, 상기 농축은 감압 농축기, 일 예로 회전 증발기를 이용하여 감압 농축할 수 있으며, 상기 건조는 일 예로 동결건조법으로 수행할 수 있다.The prepared extract or the fraction obtained by performing the fractionation process can be filtered or concentrated or dried to remove the solvent, it can be carried out both filtration, concentration and drying. Specifically, the filtration may be performed using a filter paper or a reduced pressure filter, the concentration may be concentrated under reduced pressure using a reduced pressure concentrator, for example, a rotary evaporator, and the drying may be performed by, for example, a lyophilization method.
본 발명의 일 실시예에 따르면, 어성초 추출물, 자소엽 추출물 및 녹차 추출물은 각각 독립적으로 추출되어 혼합된 것일 수 있다.According to one embodiment of the invention, Eochocho extract, cotyledon extract, and green tea extract may be each independently extracted and mixed.
상기 약재가 독립적으로 추출되고 이후 혼합되는 것이 어성초, 자소엽 및 녹차를 동시에 같이 추출하는 것보다 더 우수한 탈모 예방 및 치료 효과를 나타낼 수 있다.The medicinal herbs are independently extracted and then mixed may exhibit a better hair loss prevention and treatment effect than simultaneously extracting Echoseong, cotyledon and green tea together.
본 발명의 일 실시예에 따르면, 어성초 추출물, 자소엽 추출물 및 녹차 추출물은 발효되지 않은 것일 수 있다. 따라서 부패 등의 공정 관리상의 문제가 발생하지 않을 수 있고, 공정이 간단하여 짧은 시간 내 제조가 가능할 수 있다.According to one embodiment of the present invention, Eoseongcho extract, cotyledon extract and green tea extract may be unfermented. Therefore, a problem in process control such as corruption may not occur, and the process may be simple to enable manufacturing in a short time.
본 발명의 일 실시예에 따르면, 탈모의 예방 또는 치료용 의약 조성물은 당귀 추출물, 단삼 추출물 및 치자 추출물을 더 포함할 수 있으며, 그 함량비는 제한되진 않으나, 어성초 추출물 100 중량부 대비 당귀 추출물 50 내지 100중량부, 단삼 추출물 25 내지 75중량부 및 치자 추출물 15 내지 50중량부일 수 있다. According to an embodiment of the present invention, the pharmaceutical composition for preventing or treating hair loss may further include a Angelica extract, Salvia extract and Gardenia extract, but the content ratio is not limited, Angelica extract 50 compared to 100 parts by weight of Echochocho extract To 100 parts by weight, 25 to 75 parts by weight of Salvia extract and 15 to 50 parts by weight of gardenia extract.
당귀는 신감채의 뿌리를 한방에서 이르는 말이며 두피의 혈행을 개선시킨다.Dongguk is a word that takes the root of Shingamchae from one shot and improves the blood circulation of the scalp.
단삼은 Salvia miltiorrhiza Bunge의 뿌리로 만든 약재(한국, 중국)이다. 이는 혈액순환을 돕고, 어혈을 제거하며 사지관절 동통을 완화시킨다. 부인의 생리불순, 생리통, 산후복통, 어혈성심 복부통, 타박상 등을 치료한다. 고열로 인한 정신혼몽, 헛소리, 번조, 불면증, 피부발진, 심계항진 등을 치료한다. 약리작용은 관상동맥 확장, 콜레스테롤 강하, 혈압 강하, 간기능 활성화, 진정 항염, 항암, 항균작용이 보고되었다.Salvia is a medicinal herb made from the roots of Salvia miltiorrhiza Bunge (Korea and China). This helps with blood circulation, removes blood and relieves limb pain. Menstrual dysmenorrhea, menstrual pain, postpartum abdominal pain, bloody heart abdominal pain, bruises, etc. are treated. Heals mental fever, bullshit, annoyance, insomnia, skin rash, palpitations due to high fever. Pharmacological action has been reported to coronary dilatation, lower cholesterol, lower blood pressure, activate liver function, sedative anti-inflammatory, anticancer, antibacterial activity.
치자는 치자나무 및 동속식물의 과실로서, 가르데닌(gardenin), 펙틴(pectin), 탄닌(tannin), 크로신(crocin), 가데노시드(gardenoside), 게니포시드(geniposide), 스칸도시드(scandoside) 등의 성분이 알려져 있으며, 진저, 혈압강하작용에 대한 효능이 알려진 바 있다.Gardenia is a fruit of gardenia and related plants, including gardenin, pectin, tannin, crocin, gardenoside, geniposide, scandoside (scandoside) and other ingredients are known, the effect on the ginger, blood pressure lowering action has been known.
본 발명의 다른 일 실시예에 따르면, 탈모의 예방 또는 치료용 의약 조성물은 검정콩 추출물, 찹쌀 추출물, 다시마 추출물, 천궁 추출물, 한련초 추출물, 갈근 추출물, 감초 추출물로 이루어진 군에서 선택된 1종 이상의 추출물을 더 포함할 수 있다.According to another embodiment of the present invention, the pharmaceutical composition for preventing or treating hair loss further comprises one or more extracts selected from the group consisting of black bean extract, glutinous rice extract, kelp extract, celery extract, nasturtium extract, brown root extract, and licorice extract. It may include.
상기 각 약재 추출물들은 전술한 방법에 따라 추출된 것일 수 있다.Each of the medicinal extracts may be extracted according to the method described above.
상기 각 약재 추출물들은 탈모 예방 또는 개선 효과를 더욱 증가시킬 수 있다.Each of the medicinal extracts may further increase the effect of preventing or improving hair loss.
본 발명의 의약 조성물은 통상의 방법에 따라 산제, 과립제, 정제, 캡슐제, 현탁액, 에멀젼, 시럽, 에어로졸 등의 경구형 제형, 외용제, 좌제 및 멸균 주사용액의 형태로 제형화하여 사용될 수 있다.The pharmaceutical compositions of the present invention can be used in the form of powders, granules, tablets, capsules, suspensions, emulsions, syrups, aerosols and the like, oral dosage forms, external preparations, suppositories, and sterile injectable solutions according to conventional methods.
본 발명의 추출물을 함유하는 조성물에 함유될 수 있는 담체, 부형제 및 희석제로는 락토오즈(lactose), 덱스트로즈, 수크로스(sucrose), 솔비톨, 만니톨, 자일리톨, 에리스리톨, 말티톨, 전분, 아카시아 고무, 알지네이트, 젤라틴, 칼슘 포스페이트, 칼슘 실리케이트, 셀룰로즈, 메틸 셀룰로즈, 미정질 셀룰로스, 폴리비닐 피롤리돈, 물, 메틸히드록시벤조에이트, 프로필히드록시벤조에이트, 탈크, 마그네슘 스테아레이트 및 광물유를 들 수 있다. 제제화할 경우에는 보통 사용하는 충진제, 증량제, 결합제, 습윤제, 붕해제, 계면활성제 등의 희석제 또는 부형제를 사용하여 조제된다.Carriers, excipients and diluents that may be included in the composition containing the extract of the present invention include lactose, dextrose, sucrose, sorbitol, mannitol, xylitol, erythritol, maltitol, starch, acacia rubber , Alginate, gelatin, calcium phosphate, calcium silicate, cellulose, methyl cellulose, microcrystalline cellulose, polyvinyl pyrrolidone, water, methylhydroxybenzoate, propylhydroxybenzoate, talc, magnesium stearate and mineral oil have. When formulated, diluents or excipients such as fillers, extenders, binders, wetting agents, disintegrating agents, and surfactants are usually used.
경구투여를 위한 고형제제에는 정제, 환제, 산제, 과립제, 캡슐제 등이 포함되며, 이러한 고형제제는 상기 화합물에 적어도 하나 이상의 부형제 예를 들면, 전분, 칼슘카보네이트(calcium carbonate), 수크로스 또는 락토오스, 젤라틴 등을 섞어 조제된다. 또한 단순한 부형제 이외에 마그네슘 스테아레이트, 탈크 같은 윤활제들도 사용된다. 경구를 위한 액상 제제로는 현탁제, 내용액제, 유제, 시럽제 등이 해당되는데 흔히 사용되는 단순희석제인 물, 리퀴드 파라핀 이외에 여러 가지 부형제, 예를 들면 습윤제, 감미제, 방향제, 보존제 등이 포함될 수 있다.Solid form preparations for oral administration include tablets, pills, powders, granules, capsules, and the like, which form at least one excipient such as starch, calcium carbonate, sucrose or lactose in the compound. Mixed with gelatin. In addition to simple excipients, lubricants such as magnesium stearate and talc are also used. Oral liquid preparations include suspensions, solvents, emulsions, and syrups, and may include various excipients, such as wetting agents, sweeteners, fragrances, and preservatives, in addition to commonly used simple diluents such as water and liquid paraffin. .
비경구 투여를 위한 제제에는 멸균된 수용액, 비수성용제, 현탁제, 유제, 동결건조 제제, 좌제가 포함된다. 비수성용제, 현탁제로는 프로필렌글리콜(propylene glycol), 폴리에틸렌 글리콜, 올리브 오일과 같은 식물성 기름, 에틸올레이트와 같은 주사 가능한 에스테르 등이 사용될 수 있다. 좌제의 기제로는 위텝솔(witepsol), 마크로골, 트윈(tween) 61, 카카오지, 라우린지, 글리세로제라틴 등이 사용될 수 있다.Formulations for parenteral administration include sterile aqueous solutions, non-aqueous solvents, suspensions, emulsions, lyophilized preparations, suppositories. As the non-aqueous solvent and suspending agent, propylene glycol, polyethylene glycol, vegetable oil such as olive oil, injectable ester such as ethyl oleate and the like can be used. As the base of the suppository, witepsol, macrogol, tween 61, cacao butter, laurin butter, glycerogelatin and the like can be used.
본 발명의 의약 조성물의 사용량은 환자의 나이, 성별, 체중에 따라 달라질 수 있으나, 0.1 내지 100mg/kg으로, 바람직하게는 1 내지 10mg/kg을 일일 1회 내지 수회 투여할 수 있다. 또한 그 투여량은 투여경로, 질병의 정도, 성별, 체중, 나이 등에 따라서 증감될 수 있다. 따라서 상기 투여량은 어떠한 면으로든 본 발명의 범위를 한정하는 것은 아니다.The amount of the pharmaceutical composition of the present invention may vary depending on the age, sex, and weight of the patient, but may be 0.1 to 100 mg / kg, preferably 1 to 10 mg / kg once or several times daily. The dosage may also be increased or decreased depending on the route of administration, the severity of the disease, sex, weight, age, and the like. Therefore, the above dosage does not limit the scope of the present invention in any aspect.
본 발명의 의약 조성물은 O자형 탈모, M자형 탈모, OM복합 탈모, 옆머리 탈모, 유전성 탈모 등인 남성형 탈모, 정수리 부위의 모발이 가늘어지고 적어지는 확산형 탈모 등인 여성형 탈모, 원형 탈모에 사용될 수 있는 등 다양한 탈모 증상에 사용될 수 있다.The pharmaceutical composition of the present invention can be used for female hair loss, circular hair loss, such as O-shaped hair loss, M-shaped hair loss, OM complex hair loss, lateral hair loss, hereditary hair loss, male hair loss, diffuse hair loss in which the hair at the crown area becomes thinner and thinner, and the like. It can be used for various hair loss symptoms.
본 발명에 따른 탈모의 예방 또는 개선용 건강기능식품은 어성초 추출물, 자소엽 추출물 및 녹차 추출물을 포함하며, 어성초 추출물 100중량부에 대하여 자소엽 추출물 25 내지 75중량부 및 녹차 추출물 25 내지 75중량부를 포함한다.Health functional foods for preventing or improving hair loss according to the present invention includes Echochocho extract, Japonica leaf extract and Green tea extract, 25-75 parts by weight of Japonica leaf extract and 25-75 parts by weight of green tea extract based on 100 parts by weight of Echochocho extract Include.
각 추출물은 전술한 방법에 따라 추출된 것일 수 있다.Each extract may be one extracted according to the method described above.
본 발명에 따라 어성초 추출물, 자소엽 추출물 및 녹차 추출물의 혼합비가 상기 범위 내인 경우 탈모 예방 또는 개선 효과가 우수하게 나타날 수 있다.In accordance with the present invention, if the mixing ratio of Echochocho extract, Japonica extract and Green Tea extract is within the above range, it may be excellent in preventing hair loss or improving effect.
또한, 어성초, 자소엽 및 녹차의 시너지 효과를 극대화 시키기 위한 측면에서 바람직하게는 어성초 추출물 100중량부에 대하여 자소엽 추출물 55 내지 75중량부 및 녹차 추출물 55 내지 75중량부로 포함될 수 있으며, 더욱 바람직하게는 어성초 추출물 100중량부에 대하여 자소엽 추출물 60 내지 75중량부 및 녹차 추출물 60 내지 75중량부로 포함될 수 있다. 예컨대, 어성초 추출물, 자소엽 추출물 및 녹차 추출물은 어성초 추출물 100중량부에 대하여 자소엽 추출물 70중량부 및 녹차 추출물 70중량부로 포함될 수 있다.In addition, in terms of maximizing the synergistic effect of Echochocho, Japonica and Green Tea, the extract may include 55 to 75% by weight of Japonica Leaf Extract and 55 to 75% by weight of Green Tea Extract, and more preferably, 100 parts by weight of Echochocho extract. It may be included as 60 to 75 parts by weight of the extract of Japonica leaves and 60 to 75 parts by weight of green tea extract based on 100 parts by weight of Eochocho extract. For example, Echochocho extract, cotyledon extract and green tea extract may be included as 70 parts by weight of Japonica leaf extract and 70 parts by weight of green tea extract based on 100 parts by weight of Echocho extract.
본 발명의 일 실시예에 따르면, 어성초 추출물, 자소엽 추출물 및 녹차 추출물은 각각 독립적으로 추출되어 혼합된 것일 수 있다.According to one embodiment of the invention, Eochocho extract, cotyledon extract, and green tea extract may be each independently extracted and mixed.
상기 약재가 독립적으로 추출되고 이후 혼합되는 것이 어성초, 자소엽 및 녹차를 동시에 같이 추출하는 것보다 더 우수한 탈모 예방 및 개선 효과를 나타낼 수 있다.The medicinal herbs are independently extracted and then mixed may exhibit a better hair loss prevention and improvement effect than simultaneously extracting Echoseong, cotyledon and green tea together.
본 발명의 일 실시예에 따르면, 어성초 추출물, 자소엽 추출물 및 녹차 추출물은 발효되지 않은 것일 수 있다. 따라서 부패 등의 공정 관리상의 문제가 발생하지 않을 수 있고, 공정이 간단하여 짧은 시간 내 제조가 가능할 수 있다.According to one embodiment of the present invention, Eoseongcho extract, cotyledon extract and green tea extract may be unfermented. Therefore, a problem in process control such as corruption may not occur, and the process may be simple to enable manufacturing in a short time.
*본 발명의 일 실시예에 따르면, 탈모의 예방 또는 개선용 건강기능 식품은 당귀 추출물, 단삼 추출물 및 치자 추출물을 더 포함할 수 있으며, 그 함량비는 제한되진 않으나, 어성초 추출물 100 중량부 대비 당귀 추출물 50 내지 100중량부, 단삼 추출물 25 내지 75중량부 및 치자 추출물 15 내지 50중량부일 수 있다.* According to one embodiment of the present invention, the health functional food for preventing or improving hair loss may further include a Angelica extract, Salvia extract and Gardenia extract, the content ratio is not limited, Angelica per 100 parts by weight extract It may be 50 to 100 parts by weight of the extract, 25 to 75 parts by weight of Salvia extract and 15 to 50 parts by weight of gardenia extract.
본 발명의 다른 일 실시예에 따르면, 검정콩 추출물, 찹쌀 추출물, 다시마 추출물, 천궁 추출물, 한련초 추출물, 갈근 추출물 및 감초 추출물로 이루어진 군에서 선택된 1종 이상의 추출물을 더 포함할 수 있다.According to another embodiment of the present invention, it may further include one or more extracts selected from the group consisting of black soybean extract, glutinous rice extract, kelp extract, cheongung extract, nasturtium extract, brown root extract and licorice extract.
상기 각 약재 추출물들은 전술한 방법에 따라 추출된 것일 수 있다.Each of the medicinal extracts may be extracted according to the method described above.
상기 각 약재 추출물들은 탈모 예방 또는 개선 효과를 더욱 증가시킬 수 있다.Each of the medicinal extracts may further increase the effect of preventing or improving hair loss.
본 발명의 건강기능식품은 상기 추출물을 포함한 음료 (알콜성 음료 포함), 과실 및 그의 가공식품 (예: 과일통조림, 병조림, 잼, 마아말레이드 등), 어류, 육류 및 그 가공식품 (예: 햄, 소시지콘비이프 등), 빵류 및 면류 (예: 우동, 메밀국수, 라면, 스파게티, 마카로니 등), 과즙, 각종 드링크, 쿠키, 엿, 유제품 (예: 버터, 치즈 등), 식용식물유지, 마아가린, 식물성 단백질, 레토르트 식품, 냉동식품, 각종 조미료(예: 된장, 간장, 소스 등) 등일 수 있다.Health functional food of the present invention is a beverage containing the extract (including alcoholic beverages), fruits and processed foods thereof (e.g. canned fruit, canned food, jam, marmalade, etc.), fish, meat and processed foods thereof (e.g. Hams, sausage corn, etc.), breads and noodles (e.g. udon, soba noodles, ramen noodles, spaghetti, macaroni, etc.), fruit juices, various drinks, cookies, syrups, dairy products (e.g. butter, cheese, etc.), edible vegetable oils, Margarine, vegetable protein, retort food, frozen food, various seasonings (eg, miso, soy sauce, sauce, etc.).
또한, 본 발명의 건강기능식품은 정제, 환제, 산제, 과립제, 분말제, 캡슐제, 액제 제형 등으로 제형화된 것일 수도 있다. 이들은 담체, 희석제, 부형제 및 첨가제 중 하나 이상을 더 포함하여 제형화될 수 있다.In addition, the health functional food of the present invention may be formulated into tablets, pills, powders, granules, powders, capsules, liquid formulations and the like. These may be formulated further comprising one or more of carriers, diluents, excipients and additives.
본 발명에 더 포함될 수 있는 첨가제로는, 천연 탄수화물, 향미제, 영양제, 비타민, 광물(전해질), 풍미제(합성 풍미제, 천연 풍미제 등), 착색제, 충진제(치즈, 초콜렛 등), 팩트산 및 그의 염, 알긴산 및 그의 염, 유기산, 보호성 콜로이드 증점제, pH조절제, 안정화제, 방부제, 산화 방지제, 글리세린, 알콜, 탄산화제 및 과육으로 이루어진 군으로부터 선택된 1종 이상의 성분을 사용할 수 있다.As additives that may be further included in the present invention, natural carbohydrates, flavors, nutrients, vitamins, minerals (electrolytes), flavors (synthetic flavors, natural flavors, etc.), colorants, fillers (cheese, chocolate, etc.), facts Acids and salts thereof, alginic acid and salts thereof, organic acids, protective colloidal thickeners, pH adjusting agents, stabilizers, preservatives, antioxidants, glycerin, alcohols, carbonating agents and flesh may be used.
상술한 천연 탄수화물의 예는 모노사카라이드, 예를 들어, 포도당, 과당 등; 디사카라이드, 예를 들어 말토스, 슈크로스 등; 및 폴리사카라이드, 예를 들어 덱스트린, 시클로덱스트린 등과 같은 통상적인 당, 및 자일리톨, 소르비톨, 에리트리톨 등의 당알콜이다. 상기 향미제로서 천연 향미제(타우마틴, 스테비아 추출물(예를 들어 레바우디오시드 A, 글리시르히진등) 및 합성 향미제(사카린, 아스파르탐 등)를 유리하게 사용할 수 있다.Examples of the above-mentioned natural carbohydrates include monosaccharides such as glucose, fructose and the like; Disaccharides such as maltose, sucrose and the like; And conventional sugars such as polysaccharides such as dextrin, cyclodextrin, and sugar alcohols such as xylitol, sorbitol, and erythritol. As the flavoring agent, natural flavoring agents (tauumatin, stevia extract (for example, rebaudioside A, glycyrrhizin, etc.) and synthetic flavoring agents (saccharin, aspartame, etc.) can be advantageously used.
상기 외에 본 발명의 건강기능식품은 여러 가지 영양제, 비타민, 광물(전해질), 합성 풍미제 및 천연 풍미제 등의 풍미제, 착색제 및 중진제(치즈, 초콜릿 등), 펙트산 및 그의 염, 알긴산 및 그의 염, 유기산, 보호성 콜로이드 증점제, pH 조절제, 안정화제, 방부제, 글리세린, 알콜, 탄산 음료에 사용되는 탄산화제 등을 함유할 수 있다. 그 밖에 본 발명의 건강기능식품은 천연 과일 쥬스 및 야채 음료의 제조를 위한 과육을 함유할 수 있다. 이러한 성분은 독립적으로 또는 조합하여 사용할 수 있다.In addition to the above, the health functional food of the present invention includes various nutrients, vitamins, minerals (electrolytes), flavors such as synthetic flavors and natural flavors, coloring and neutralizing agents (such as cheese and chocolate), pectic acid and salts thereof, alginic acid And salts thereof, organic acids, protective colloid thickeners, pH adjusters, stabilizers, preservatives, glycerin, alcohols, carbonation agents used in carbonated beverages, and the like. In addition, the health functional food of the present invention may contain flesh for preparing natural fruit juice and vegetable beverage. These components can be used independently or in combination.
상기 담체, 부형제, 희석제 및 첨가제의 구체적인 예로는 이에 한정하는 것은 아니나, 락토즈, 덱스트로즈, 슈크로즈, 솔비톨, 만니톨, 에리스리톨, 전분, 아카시아 고무, 인산칼슘, 알지네이트, 젤라틴, 칼슘 포스페이트, 칼슘 실리케이트, 미세결정성 셀룰로즈, 폴리비닐피롤리돈, 셀룰로즈, 폴리비닐피롤리돈, 메틸셀룰로즈, 물, 설탕시럽, 메틸셀룰로즈, 메틸 하이드록시 벤조에이트, 프로필하이드록시 벤조에이트, 활석, 스테아트산 마그네슘 및 미네랄 오일로 이루어진 그룹으로부터 선택된 1종 이상이 사용되는 것이 바람직하다.Specific examples of the carrier, excipient, diluent and additives include, but are not limited to, lactose, dextrose, sucrose, sorbitol, mannitol, erythritol, starch, acacia rubber, calcium phosphate, alginate, gelatin, calcium phosphate, calcium Silicates, microcrystalline cellulose, polyvinylpyrrolidone, cellulose, polyvinylpyrrolidone, methylcellulose, water, sugar syrup, methylcellulose, methyl hydroxy benzoate, propyl hydroxy benzoate, talc, magnesium stearate And at least one selected from the group consisting of mineral oils.
상기 상술한 제형 내 유효성분으로서의 본 발명의 건강기능식품의 함량은 사용 형태 및 목적, 사용자 상태, 증상의 종류 및 경중 등에 의하여 적절하게 조절할 수 있으며, 고형분 중량 기준으로 0.001 내지 99.9 중량%, 바람직하게는 0.01 내지 50 중량%일 수 있으나, 이에 한정되지 않는다.The content of the health functional food of the present invention as an active ingredient in the above-described formulations can be appropriately adjusted according to the use form and purpose, user condition, type of symptom and the weight, etc., 0.001 to 99.9% by weight, based on the solid content weight, preferably May be 0.01 to 50% by weight, but is not limited thereto.
또한, 본 발명에 따른 탈모의 예방 또는 개선용 화장료 조성물은 어성초 추출물, 자소엽 추출물 및 녹차 추출물을 포함하며, 상기 어성초 추출물 100중량부에 대하여 자소엽 추출물 25 내지 75중량부 및 녹차 추출물 25 내지 75중량부를 포함한다.In addition, the cosmetic composition for preventing or improving hair loss according to the present invention includes Echochocho extract, Japonica leaf extract and Green tea extract, 25-75 parts by weight of Japonica leaf extract and Green Tea extract 25-75 with respect to 100 parts by weight of the Echochocho extract It includes parts by weight.
각 추출물은 전술한 방법에 따라 추출된 것일 수 있다.Each extract may be one extracted according to the method described above.
본 발명에 따라 어성초 추출물, 자소엽 추출물 및 녹차 추출물의 혼합비가 상기 범위 내인 경우 탈모 예방 또는 개선 효과가 우수하게 나타날 수 있다.In accordance with the present invention, if the mixing ratio of Echochocho extract, Japonica extract and Green Tea extract is within the above range, it may be excellent in preventing hair loss or improving effect.
또한, 어성초, 자소엽 및 녹차의 시너지 효과를 극대화 시키기 위한 측면에서 바람직하게는 어성초 추출물 100중량부에 대하여 자소엽 추출물 55 내지 75중량부 및 녹차 추출물 55 내지 75중량부로 포함될 수 있으며, 더욱 바람직하게는 어성초 추출물 100중량부에 대하여 자소엽 추출물 60 내지 75중량부 및 녹차 추출물 60 내지 75중량부로 포함될 수 있다. 예컨대, 어성초 추출물, 자소엽 추출물 및 녹차 추출물은 어성초 추출물 100중량부에 대하여 자소엽 추출물 70중량부 및 녹차 추출물 70중량부로 포함될 수 있다.In addition, in terms of maximizing the synergistic effect of Echochocho, Japonica and Green Tea, the extract may include 55 to 75% by weight of Japonica Leaf Extract and 55 to 75% by weight of Green Tea Extract, and more preferably, 100 parts by weight of Echochocho extract. It may be included as 60 to 75 parts by weight of the extract of Japonica leaves and 60 to 75 parts by weight of green tea extract based on 100 parts by weight of Eochocho extract. For example, Echochocho extract, cotyledon extract and green tea extract may be included as 70 parts by weight of Japonica leaf extract and 70 parts by weight of green tea extract based on 100 parts by weight of Echocho extract.
본 발명의 일 실시예에 따르면, 어성초 추출물, 자소엽 추출물 및 녹차 추출물은 각각 독립적으로 추출되어 혼합된 것일 수 있다.According to one embodiment of the invention, Eochocho extract, cotyledon extract, and green tea extract may be each independently extracted and mixed.
상기 약재가 독립적으로 추출되고 이후 혼합되는 것이 어성초, 자소엽 및 녹차를 동시에 같이 추출하는 것보다 더 우수한 탈모 예방, 개선 효과를 나타낼 수 있다.The medicinal herbs are independently extracted and then mixed may exhibit a better hair loss prevention and improvement effect than simultaneously extracting Echoseong, cotyledon and green tea together.
본 발명의 일 실시예에 따르면, 어성초 추출물, 자소엽 추출물 및 녹차 추출물은 발효되지 않은 것일 수 있다. 따라서 부패 등의 공정 관리상의 문제가 발생하지 않을 수 있고, 공정이 간단하여 짧은 시간 내 제조가 가능할 수 있다.According to one embodiment of the present invention, Eoseongcho extract, cotyledon extract and green tea extract may be unfermented. Therefore, a problem in process control such as corruption may not occur, and the process may be simple to enable manufacturing in a short time.
본 발명의 일 실시예에 따르면, 탈모의 예방 또는 개선용 화장료 조성물은 당귀 추출물, 단삼 추출물 및 치자 추출물을 더 포함할 수 있으며, 그 함량비는 제한되진 않으나, 어성초 추출물 100 중량부 대비 당귀 추출물 50 내지 100중량부, 단삼 추출물 25 내지 75중량부 및 치자 추출물 15 내지 50중량부일 수 있다.According to one embodiment of the present invention, the cosmetic composition for preventing or improving hair loss may further include a Angelica extract, Salvia extract and Gardenia extract, the content ratio is not limited, Angelica extract 50 compared to 100 parts by weight Eochocho extract To 100 parts by weight, 25 to 75 parts by weight of Salvia extract and 15 to 50 parts by weight of gardenia extract.
본 발명의 다른 일 실시예에 따르면, 탈모의 예방 또는 개선용 화장료 조성물은 검정콩 추출물, 찹쌀 추출물, 다시마 추출물, 천궁 추출물, 한련초 추출물, 갈근 추출물, 감초 추출물로 이루어진 군에서 선택된 1종 이상의 추출물을 더 포함할 수 있다.According to another embodiment of the present invention, the cosmetic composition for preventing or improving hair loss is more than one extract selected from the group consisting of black soybean extract, glutinous rice extract, kelp extract, cheongung extract, nasturtium extract, brown root extract, licorice extract It may include.
상기 각 약재 추출물들은 전술한 방법에 따라 추출된 것일 수 있다.Each of the medicinal extracts may be extracted according to the method described above.
상기 각 약재 추출물들은 탈모 예방 또는 개선 효과를 더욱 증가시킬 수 있다.Each of the medicinal extracts may further increase the effect of preventing or improving hair loss.
본 발명의 화장료 조성물은 수용성 비타민, 유용성 비타민, 고분자 펩티드, 고분자 다당, 스핑고 지질 및 해초 엑기스로 이루어진 군에서 선택된 조성물을 더 포함할 수 있다.The cosmetic composition of the present invention may further include a composition selected from the group consisting of water-soluble vitamins, oil-soluble vitamins, polymer peptides, polymer polysaccharides, sphingolipids, and seaweed extracts.
수용성 비타민으로는 화장품에 배합 가능한 것이라면 어떠한 것이라도 되지만, 바람직하게는 비타민 B1, 비타민 B2, 비타민 B6, 피리독신, 염산피리독신, 비타민 B12, 판토텐산, 니코틴산, 니코틴산아미드, 엽산, 비타민 C, 비타민 H 등을 들 수 있으며, 그들의 염(티아민염산염, 아스코르빈산나트륨염 등)이나 유도체(아스코르빈산-2-인산나트륨염, 아스코르빈산-2-인산마그네슘염 등)도 본 발명에서 사용할 수 있는 수용성 비타민에 포함된다. 수용성 비타민은 미생물 변환법, 미생물의 배양물로부터의 정제법, 효소법 또는 화학 합성법 등의 통상의 방법에 의해 수득할 수 있다.The water-soluble vitamin may be any compound that can be incorporated into cosmetics, but preferably vitamin B1, vitamin B2, vitamin B6, pyridoxine, pyridoxine, vitamin B12, pantothenic acid, nicotinic acid, nicotinic acid amide, folic acid, vitamin C, vitamin H, and the like. And salts thereof (thiamine hydrochloride, sodium ascorbate salt, etc.) and derivatives (ascorbic acid-2-sodium phosphate salt, ascorbic acid-2-magnesium phosphate salt, etc.) can also be used in the present invention. Included in The water-soluble vitamins can be obtained by conventional methods such as microbial transformation, purification from microorganism culture, enzyme or chemical synthesis.
유용성 비타민으로는 화장품에 배합 가능한 것이라면 어떠한 것이라도 되지만, 바람직하게는 비타민 A, 카로틴, 비타민 D2, 비타민 D3, 비타민 E(d1-알파 토코페롤, d-알파 토코페롤, d-알파 토코페롤) 등을 들 수 있으며, 그들의 유도체(팔미틴산아스코르빈, 스테아르산아스코르빈, 디팔미틴산아스코르빈, 아세트산 dl-알파 토코페롤, 니코틴산 dl-알파 토코페롤비타민 E, DL-판토테닐알코올, D-판토테닐알코올, 판토테닐에틸에테르 등) 등도 본 발명에서 사용되는 유용성 비타민에 포함된다. 유용성 비타민은 미생물 변환법, 미생물의 배양물로부터의 정제법, 효소 또는 화학 합성법 등의 통상의 방법에 의해 취득할 수 있다.The oil-soluble vitamin may be any compound that can be formulated in cosmetics, but preferably vitamin A, carotene, vitamin D2, vitamin D3, vitamin E (d1-alpha tocopherol, d-alpha tocopherol, d-alpha tocopherol) and the like. Derivatives thereof (ascorbic palmitate, ascorbic stearate, ascorbic acid dipalmitate, dl-alpha tocopherol acetate, dl-alpha tocopherolvitamin E, DL-pantothenyl alcohol, D-pantothenyl alcohol, pantothenyl) Ethyl ether) and the like are also included in the oil-soluble vitamins used in the present invention. Oil-soluble vitamins can be obtained by conventional methods such as microbial transformation, purification of microorganism culture, enzyme or chemical synthesis.
고분자 펩티드로는 화장품에 배합 가능한 것이라면 어떠한 것이라도 되지만, 바람직하게는 콜라겐, 가수 분해 콜라겐, 젤라틴, 엘라스틴, 가수 분해 엘라스틴, 케라틴 등을 들 수 있다. 고분자 펩티드는 미생물의 배양액으로부터의 정제법, 효소법 또는 화학 합성법 등의 통상의 방법에 의해 정제 취득할 수 있으며, 또는 통상 돼지나 소 등의 진피, 누에의 견섬유 등의 천연물로부터 정제하여 사용할 수 있다.The polymer peptide may be any compound as long as it can be incorporated into cosmetics. Preferably, collagen, hydrolyzed collagen, gelatin, elastin, hydrolyzed elastin, keratin and the like can be given. Polymeric peptides can be purified and obtained by conventional methods such as purification from microbial cultures, enzymatic methods or chemical synthesis methods, or can be purified and used from natural products such as dermis and pig silk such as pigs and cattle.
고분자 다당으로는 화장품에 배합 가능한 것이라면 어떠한 것이라도 되지만, 바람직하게는 히드록시에틸셀룰로오스, 크산탄검, 히알루론산나트륨, 콘드로이틴 황산 또는 그 염(나트륨염 등) 등을 들 수 있다. 예를 들어, 콘드로이틴 황산 또는 그 염 등은 통상 포유동물이나 어류로부터 정제하여 사용할 수 있다.The polymer polysaccharide may be any compound as long as it can be incorporated into cosmetics. Preferably, hydroxyethyl cellulose, xanthan gum, sodium hyaluronate, chondroitin sulfate or a salt thereof (sodium salt, etc.) may be mentioned. For example, chondroitin sulfate or its salt, etc. can be normally purified from a mammal or fish.
스핑고 지질로는 화장품에 배합 가능한 것이라면 어떠한 것이라도 되지만, 바람직하게는 세라미드, 피토스핑고신, 스핑고당지질 등을 들 수 있다. 스핑고 지질은 통상 포유류, 어류, 패류, 효모 또는 식물 등으로부터 통상의 방법에 의해 정제하거나 화학 합성법에 의해 취득할 수 있다.The sphingolipid may be any compound as long as it can be incorporated into cosmetics. Preferably, ceramide, phytosphingosine, sphingosaccharide lipid and the like can be given. Sphingo lipids can usually be purified from mammals, fish, shellfish, yeasts or plants by conventional methods or obtained by chemical synthesis.
해초 엑기스로는 화장품에 배합 가능한 것이라면 어떠한 것이라도 되지만, 바람직하게는 갈조 엑기스, 홍조 엑기스, 녹조 엑기스 등을 들 수 있으며, 또, 이들의 해초 엑기스로부터 정제된 칼라기난, 아르긴산, 아르긴산나트륨, 아르긴산칼륨 등도 본 발명에서 사용되는 해초 엑기스에 포함된다. 해초 엑기스는 해초로부터 통상의 방법에 의해 정제하여 취득할 수 있다.The seaweed extract may be any compound as long as it can be blended into cosmetics. Preferably, the seaweed extract may include brown algae extract, red algae extract, green algae extract, and the like. Also, calginine, arginic acid, sodium arginate, Potassium arginate and the like are also included in the seaweed extract used in the present invention. Seaweed extract can be obtained by purification from seaweed by conventional methods.
본 발명의 화장료 조성물은 상기 필수 성분과 더불어 필요에 따라 통상 화장료에 배합되는 다른 성분을 더 포함할 수 있다.The cosmetic composition of the present invention may further include other components which are usually formulated into cosmetics as necessary in addition to the essential components.
배합 가능한 성분으로는 유지 성분, 보습제, 에몰리엔트제, 계면 활성제, 유기 및 무기 안료, 유기 분체, 자외선 흡수제, 방부제, 살균제, 산화 방지제, 식물 추출물, pH 조정제, 알콜, 색소, 향료, 혈행 촉진제, 냉감제, 제한(制汗)제, 정제수 등을 들 수 있다.Ingredients that can be formulated include fats and oils, moisturizers, emollients, surfactants, organic and inorganic pigments, organic powders, UV absorbers, preservatives, fungicides, antioxidants, plant extracts, pH adjusters, alcohols, pigments, fragrances, and blood circulation accelerators. , A cooling agent, a restriction | limiting agent, purified water, etc. are mentioned.
유지 성분으로는 에스테르계 유지, 탄화수소계 유지, 실리콘계 유지, 불소계 유지, 동물 유지, 식물 유지 등을 들 수 있다.Examples of the fat or oil component include ester fats, hydrocarbon fats, silicone fats, fluorine fats, animal fats, and vegetable fats and oils.
에스테르계 유지로는 트리2-에틸헥산산글리세릴, 2-에틸헥산산세틸, 미리스틴산이소프로필, 미리스틴산부틸, 팔미틴산이소프로필, 스테아르산에틸, 팔미틴산옥틸, 이소스테아르산이소세틸, 스테아르산부틸, 리놀레산에틸, 리놀레산이소프로필, 올레인산에틸, 미리스틴산이소세틸, 미리스틴산이소스테아릴, 팔미틴산이소스테아릴, 미리스틴산옥틸도데실, 이소스테아르산이소세틸, 세바신산디에틸, 아디핀산디이소프로필, 네오펜탄산이소알킬, 트리(카프릴, 카프린산)글리세릴, 트리2-에틸헥산산트리메틸롤프로판, 트리이소스테아르산트리메틸롤프로판, 테트라2-에틸헥산산펜타엘리슬리톨, 카프릴산세틸, 라우린산데실, 라우린산헥실, 미리스틴산데실, 미리스틴산미리스틸, 미리스틴산세틸, 스테아르산스테아릴, 올레인산데실, 리시노올레인산세틸, 라우린산이소스테아릴, 미리스틴산이소트리데실, 팔미틴산이소세틸, 스테아르산옥틸, 스테아르산이소세틸, 올레인산이소데실, 올레인산옥틸도데실, 리놀레산옥틸도데실, 이소스테아르산이소프로필, 2-에틸헥산산세토스테아릴, 2-에틸헥산산스테아릴, 이소스테아르산헥실, 디옥탄산에틸렌글리콜, 디올레인산에틸렌글리콜, 디카프린산프로필렌글리콜, 디(카프릴,카프린산)프로필렌글리콜, 디카프릴산프로필렌글리콜, 디카프린산네오펜틸글리콜, 디옥탄산네오펜틸글리콜, 트리카프릴산글리세릴, 트리운데실산글리세릴, 트리이소팔미틴산글리세릴, 트리이소스테아르산글리세릴, 네오펜탄산옥틸도데실, 옥탄산이소스테아릴, 이소노난산옥틸, 네오데칸산헥실데실, 네오데칸산옥틸도데실, 이소스테아르산이소세틸, 이소스테아르산이소스테아릴, 이소스테아르산옥틸데실, 폴리글리세린올레인산에스테르, 폴리글리세린이소스테아르산에스테르, 시트르산트리이소세틸, 시트르산트리이소알킬, 시트르산트리이소옥틸, 락트산라우릴, 락트산미리스틸, 락트산세틸, 락트산옥틸데실, 시트르산트리에틸, 시트르산아세틸트리에틸, 시트르산아세틸트리부틸, 시트르산트리옥틸, 말산디이소스테아릴, 히드록시스테아르산 2-에틸헥실, 숙신산디2-에틸헥실, 아디핀산디이소부틸, 세바신산디이소프로필, 세바신산디옥틸, 스테아르산콜레스테릴, 이소스테아르산콜레스테릴, 히드록시스테아르산콜레스테릴, 올레인산콜레스테릴, 올레인산디히드로콜레스테릴, 이소스테아르산피트스테릴, 올레인산피트스테릴, 12-스테알로일히드록시스테아르산이소세틸, 12-스테알로일히드록시스테아르산스테아릴, 12-스테알로일히드록시스테아르산이소스테아릴 등의 에스테르계 등을 들 수 있다.As ester fats and oils, glyceryl tri2-ethylhexanoate, cetyl 2-ethylhexanoate, isopropyl myristate, butyl mystinate, isopropyl palmitate, ethyl stearate, octyl palmitate, isocetyl isostearate, stearic acid Butyl acid, ethyl linoleate, isopropyl linoleate, ethyl oleate, isocetyl acid isocetyl, isostyl acid isostearyl, isostaryl palmitate, octylate acid octylate dodecyl, isostearic acid isetyl, diethyl sebacinate, adidi Diisopropyl phosphate, isoalkyl neopentane, tri (capryl, capric acid) glyceryl, trimethyl ethyl trimethylolpropane, trimethyl stearate trimethylol propane, tetra 2-ethylhexanopentane Tall, cetyl caprylate, lauric decyl laurate, hexyl laurate, myristicate decyl, myristic acid myristyl, myristicate cetyl, stearyl stearate, decyl oleate, risinooleate, Isostearyl laurate, isotridecyl myristin, isocetyl palmitate, octyl stearate, isocetyl stearate, isodecyl oleate, octyl dodecyl oleate, octyl dodecyl linoleate, isopropyl isopropyl acid, 2- Cetostearyl ethylhexanoate, stearyl 2-ethylhexanoate, hexyl isostearate, ethylene glycol dioctanoate, ethylene glycol dioleate, propylene glycol dicapric acid, propylene glycol di (capryl, capric acid) propylene glycol, dicapryl Acid propylene glycol, dipentane neopentyl glycol, dioctanoate neopentyl glycol, tricaprylate glyceryl, triundecyl glyceryl, triisopalmitate glyceryl, triisostearic acid glyceryl neopentane dodecyl, Isostearyl octanoate, octyl isononate, hexyldecyl neodecanoate, octyldodecyl neodecanoate, isocetyl isostearate, isstearyl isostearate, Octyl stearate, polyglycerol oleic acid ester, polyglycerin isostearic acid ester, triisocetyl citrate, triisoalkyl citrate, triisoctyl citrate, lauryl lactate, myritic lactate, cetyl lactate, octyl lactate, triethyl citrate , Acetyl triethyl citrate, acetyl tributyl citrate, trioctyl citrate, diisostearyl malic acid, 2-ethylhexyl hydroxystearate, diethyl ethyl succinate, diisobutyl adipicate, diisopropyl sebacate, seba Dioctyl Citrate, Cholesterol Stearate, Cholesterol Isostearate, Cholesterol Hydroxystearate, Cholesterol Oleate, Dihydrocholesteryl Oleate, Pitsteryl Isotearate, Pysterol Oleate, 12 -Steloylhydroxystearate isocetyl, 12-stealoylhydroxystearate stearyl, 12-stealoyl Ester system, such as hydroxystearic acid isostearyl, etc. are mentioned.
탄화 수소계 유지로는 스쿠알렌, 유동 파라핀, 알파-올레핀올리고머, 이소파라핀, 세레신, 파라핀, 유동 이소파라핀, 폴리부덴, 마이크로크리스탈린왁스, 와셀린 등의 탄화 수소계 유지 등을 들 수 있다.Hydrocarbon-based oils, such as squalene, liquid paraffin, alpha-olefin oligomer, isoparaffin, ceresin, paraffin, liquid isoparaffin, polybutene, microcrystal wax, and petrolatum, are mentioned as hydrocarbon-based oils and fats.
실리콘계 유지로는 폴리메틸실리콘, 메틸페닐실리콘, 메틸시클로폴리실록산, 옥타메틸폴리실록산, 데카메틸폴리실록산, 도데카메틸시클로실록산, 디메틸실록산ㆍ메틸세틸옥시실록산 공중합체, 디메틸실록산ㆍ메틸스테알록시실록산 공중합체, 알킬 변성 실리콘유, 아미노 변성 실리콘유 등을 들 수 있다.As the silicone-based fats and oils, polymethylsilicone, methylphenylsilicone, methylcyclopolysiloxane, octamethylpolysiloxane, decamethylpolysiloxane, dodecamethylcyclosiloxane, dimethylsiloxane, methylcetyloxysiloxane copolymer, dimethylsiloxane and methylsteoxysiloxane copolymer, Alkyl modified silicone oil, amino modified silicone oil, etc. are mentioned.
불소계 유지로는 퍼플루오로폴리에테르 등을 들 수 있다.Perfluoro polyether etc. are mentioned as fluorine-based fats and oils.
동물 또는 식물 유지로는 아보카도유, 아르몬드유, 올리브유, 참깨유, 쌀겨유, 새플라워유, 대두유, 옥수수유, 유채유, 행인(杏仁)유, 팜핵유, 팜유, 피마자유, 해바라기유, 포도종자유, 면실유, 야자유, 쿠쿠이너트유, 소맥배아유, 쌀 배아유, 시아버터, 월견초유, 마커데이미아너트유, 메도홈유, 난황유, 우지(牛脂), 마유, 밍크유, 오렌지라피유, 호호바유, 캔데리러왁스, 카르나바왁스, 액상 라놀린, 경화피마자유 등의 동물 또는 식물 유지를 들 수 있다.Animal or vegetable fats and oils include avocado oil, almond oil, olive oil, sesame oil, rice bran oil, soybean oil, soybean oil, corn oil, rapeseed oil, almond oil, palm kernel oil, palm oil, castor oil, sunflower oil, grapes. Seed oil, Cottonseed oil, Palm oil, Cuckoo nut oil, Wheat germ oil, Rice germ oil, Shea butter, Walnut colostrum, Marker demia nut oil, Meadow home oil, Egg yolk oil, Uji, Horse oil, Mink oil, Orange rape oil, Jojoba Animal or vegetable fats and oils, such as oil, candler wax, carnava wax, liquid lanolin, hardened castor oil, etc. are mentioned.
보습제로는 수용성 저분자 보습제, 지용성 분자 보습제, 수용성 고분자, 지용성 고분자 등을 들 수 있다.Examples of the moisturizing agent include a water-soluble low molecular moisturizer, a fat-soluble molecular moisturizer, a water-soluble polymer, and a fat-soluble polymer.
수용성 저분자 보습제로는 세린, 글루타민, 솔비톨, 만니톨, 피롤리돈-카르복실산나트륨, 글리세린, 프로필렌글리콜, 1,3-부틸렌글리콜, 에틸렌글리콜, 폴리에틸렌글리콜B(중합도 n = 2 이상), 폴리프로필렌글리콜(중합도 n = 2 이상), 폴리글리세린B(중합도 n = 2 이상), 락트산, 락트산염 등을 들 수 있다.Water-soluble low molecular humectants include serine, glutamine, sorbitol, mannitol, pyrrolidone-sodium carboxylate, glycerin, propylene glycol, 1,3-butylene glycol, ethylene glycol, polyethylene glycol B (polymerization degree n = 2 or more), poly Propylene glycol (polymerization degree n = 2 or more), polyglycerol B (polymerization degree n = 2 or more), lactic acid, lactic acid salt, etc. are mentioned.
지용성 저분자 보습제로는 콜레스테롤, 콜레스테롤에스테르 등을 들 수 있다.Examples of the fat-soluble low molecular humectants include cholesterol and cholesterol esters.
수용성 고분자로는 카르복시비닐폴리머, 폴리아스파라긴산염, 트라가칸트, 크산탄검, 메틸셀룰로오스, 히드록시메틸셀룰로오스, 히드록시에틸셀룰로오스, 히드록시프로필셀룰로오스, 카르복시메틸셀룰로오스, 수용성 키틴, 키토산, 덱스트린 등을 들 수 있다.As the water-soluble polymer, carboxyvinyl polymer, polyasparaginate, tragacanth, xanthan gum, methyl cellulose, hydroxymethyl cellulose, hydroxyethyl cellulose, hydroxypropyl cellulose, carboxymethyl cellulose, water soluble chitin, chitosan, dextrin, etc. Can be mentioned.
지용성 고분자로는 폴리비닐피롤리돈ㆍ에이코센 공중합체, 폴리비닐피롤리돈ㆍ헥사데센 공중합체, 니트로셀룰로오스, 덱스트린지방산에스테르, 고분자 실리콘 등을 들 수 있다.Examples of the fat-soluble polymers include polyvinylpyrrolidone-eicosene copolymers, polyvinylpyrrolidone-hexadecene copolymers, nitrocellulose, dextrin fatty acid esters, polymer silicones, and the like.
에몰리엔트제로는 장쇄아실글루타민산콜레스테릴에스테르, 히드록시스테아르산콜레스테릴, 12-히드록시스테아르산, 스테아르산, 로진산, 라놀린지방산콜레스테릴에스테르 등을 들 수 있다.Examples of the emollient agent include long-chain acyl glutamic acid cholesteryl ester, hydroxy stearic acid cholesterol, 12-hydroxystearic acid, stearic acid, rosin acid, lanolin fatty acid cholesteryl ester, and the like.
계면 활성제로는 비이온성 계면 활성제, 음이온성 계면 활성제, 양이온성 계면 활성제, 양성 계면 활성제 등을 들 수 있다.As surfactant, nonionic surfactant, anionic surfactant, cationic surfactant, an amphoteric surfactant, etc. are mentioned.
비이온성 계면 활성제로는 자기 유화형 모노스테아르산글리세린, 프로필렌글리콜지방산에스테르, 글리세린지방산에스테르, 폴리글리세린지방산에스테르, 솔비탄지방산에스테르, POE(폴리옥시에틸렌) 솔비탄지방산에스테르, POE 솔비트지방산에스테르, POE 글리세린지방산에스테르, POE 알킬에테르, POE 지방산에스테르, POE 경화피마자유, POE 피마자유, POEㆍPOP(폴리옥시에틸렌ㆍ폴리옥시프로필렌) 공중합체, POEㆍPOP 알킬에테르, 폴리에테르변성실리콘, 라우린산알카놀아미드, 알킬아민옥시드, 수소첨가대두인지질 등을 들 수 있다.Nonionic surfactants include self-emulsifying glycerin monostearate, propylene glycol fatty acid esters, glycerin fatty acid esters, polyglycerol fatty acid esters, sorbitan fatty acid esters, POE (polyoxyethylene) sorbitan fatty acid esters, POE sorbitan fatty acid esters, POE glycerin fatty acid ester, POE alkyl ether, POE fatty acid ester, POE hardened castor oil, POE castor oil, POE / POP (polyoxyethylene / polyoxypropylene) copolymer, POE / POP alkyl ether, polyether modified silicone, laurin Acid alkanolamide, alkylamine oxide, hydrogenated soybean phospholipid, etc. are mentioned.
음이온성 계면 활성제로는 지방산비누, 알파-아실술폰산염, 알킬술폰산염, 알킬알릴술폰산염, 알킬나프탈렌술폰산염, 알킬황산염, POE 알킬에테르황산염, 알킬아미드황산염, 알킬인산염, POE 알킬인삼염, 알킬아미드인산염, 알킬로일알킬타우린염, N-아실아미노산염, POE 알킬에테르카르복실산염, 알킬술포숙신산염, 알킬술포아세트산나트륨, 아실화 가수분해 콜라겐펩티드염, 퍼플루오로알킬인산에스테르 등을 들 수 있다.Anionic surfactants include fatty acid soaps, alpha-acyl sulfonates, alkyl sulfonates, alkyl allyl sulfonates, alkyl naphthalene sulfonates, alkyl sulfates, POE alkyl ether sulfates, alkylamide sulfates, alkyl phosphates, POE alkyl phosphorus salts, alkyls Amide phosphate, alkyloylalkyl taurine salt, N-acylamino acid salt, POE alkyl ether carboxylate, alkyl sulfosuccinate salt, sodium alkyl sulfo acetate, acylated hydrolyzed collagen peptide salt, perfluoroalkyl phosphate ester, etc. Can be.
양이온성 계면 활성제로는 염화알킬트리메틸암모늄, 염화스테아릴트리메틸암모늄, 브롬화스테아릴트리메틸암모늄, 염화세토스테아릴트리메틸암모늄, 염화디스테아릴디메틸암모늄, 염화스테아릴디메틸벤질암모늄, 브롬화베헤닐트리메틸암모늄, 염화벤잘코늄, 스테아르산디에틸아미노에틸아미드, 스테아르산디메틸아미노프로필아미드, 라놀린 유도체 제 4급 암모늄염 등을 들 수 있다.Cationic surfactants include alkyltrimethylammonium chloride, stearyltrimethylammonium chloride, stearyltrimethylammonium chloride, cetostearyltrimethylammonium chloride, distearyldimethylammonium chloride, stearyldimethylbenzylammonium, behenyltrimethylammonium bromide, Benzalkonium chloride, diethylaminoethyl stearate, dimethylaminopropyl stearate, lanolin derivatives, quaternary ammonium salts, and the like.
양성 계면 활성제로는 카르복시베타인형, 아미드베타인형, 술포베타인형, 히드록시술포베타인형, 아미드술포베타인형, 포스포베타인형, 아미노카르복실산염형, 이미다졸린 유도체형, 아미드아민형 등의 양성 계면 활성제 등을 들 수 있다.Amphoteric surfactants include carboxybetaine type, amidebetaine type, sulfobetaine type, hydroxysulfobetaine type, amide sulfobetaine type, phosphobetaine type, aminocarboxylate type, imidazoline derivative type, amideamine type and the like. Amphoteric surfactants; and the like.
유기 및 무기 안료로는 규산, 무수규산, 규산마그네슘, 탤크, 세리사이트, 마이카, 카올린, 벵갈라, 클레이, 벤토나이트, 티탄피막운모, 옥시염화비스무트, 산화지르코늄, 산화마그네슘, 산화아연, 산화티탄, 산화알루미늄, 황산칼슘, 황산바륨, 황산마그네슘, 탄산칼슘, 탄산마그네슘, 산화철, 군청, 산화크롬, 수산화크롬, 칼라민 및 이들의 복합체등의 무기 안료; 폴리아미드, 폴리에스테르, 폴리프로필렌, 폴리스티렌, 폴리우레탄, 비닐수지, 요소수지, 페놀수지, 불소수지, 규소수지, 아크릴수지, 멜라민수지, 에폭시수지, 폴리카보네이트수지, 디비닐벤젠ㆍ스티렌 공중합체, 실크파우더, 셀룰로오스, CI 피그먼트옐로우, CI 피그먼트오렌지 등의 유기 안료 및 이들의 무기 안료와 유기 안료의 복합 안료 등을 들 수 있다.Organic and inorganic pigments include silicic acid, silicic anhydride, magnesium silicate, talc, sericite, mica, kaolin, bengal, clay, bentonite, titanium film mica, bismuth oxychloride, zirconium oxide, magnesium oxide, zinc oxide, titanium oxide, and oxide Inorganic pigments such as aluminum, calcium sulfate, barium sulfate, magnesium sulfate, calcium carbonate, magnesium carbonate, iron oxide, ultramarine, chromium oxide, chromium hydroxide, coloramine and composites thereof; Polyamide, polyester, polypropylene, polystyrene, polyurethane, vinyl resin, urea resin, phenol resin, fluorine resin, silicon resin, acrylic resin, melamine resin, epoxy resin, polycarbonate resin, divinylbenzene, styrene copolymer, Organic pigments such as silk powder, cellulose, CI pigment yellow, CI pigment orange, and composite pigments of these inorganic pigments and organic pigments;
유기 분체로는 스테아르산칼슘 등의 금속비누; 세틸린산아연나트륨, 라우릴린산아연, 라우릴린산칼슘 등의 알킬인산금속염; N-라우로일-베타-알라닌칼슘, N-라우로일-베타-알라닌아연, N-라우로일글리신칼슘 등의 아실아미노산 다가금속염; N-라우로일-타우린칼슘, N-팔미토일-타우린칼슘 등의 아미드술폰산 다가금속염; N-엡실론-라우로일-L-리진, N-엡실론-팔미토일리진, N-알파-파리토일올니틴, N-알파-라우로일아르기닌, N-알파-경화우지지방산아실아르기닌 등의 N-아실염기성아미노산; N-라우로일글리실글리신 등의 N-아실폴리펩티드; 알파-아미노카프릴산, 알파-아미노라우린산 등의 알파-아미노지방산; 폴리에틸렌, 폴리프로필렌, 나일론, 폴리메틸메타크릴레이트, 폴리스티렌, 디비닐벤젠ㆍ스티렌 공중합체, 사불화에틸렌 등을 들 수 있다.Examples of the organic powder include metal soaps such as calcium stearate; Alkyl phosphate metal salts such as zinc sodium cetyl acid, zinc lauryl acid and calcium laurate; Acylamino acid polyvalent metal salts such as N-lauroyl-beta-alanine calcium, N-lauroyl-beta-alanine zinc, and N-lauroylglycine calcium; Amide sulfonic acid polyvalent metal salts, such as N-lauroyl-taurine calcium and N-palmitoyl-taurine calcium; N-epsilon-lauroyl-L-lysine, N-epsilon-palmitolyzine, N-alpha-paratoylol nitin, N-alpha-lauroyl arginine, N-alpha-cured fatty acid acyl arginine Acyl basic amino acids; N-acylpolypeptides, such as N-lauroyl glycyl glycine; Alpha-amino fatty acids such as alpha-aminocaprylic acid and alpha-aminolauric acid; Polyethylene, polypropylene, nylon, polymethyl methacrylate, polystyrene, divinylbenzene-styrene copolymer, ethylene tetrafluoride and the like.
자외선 흡수제로는 파라아미노벤조산, 파라아미노벤조산에틸, 파라아미노벤조산아밀, 파라아미노벤조산옥틸, 살리실산에틸렌글리콜, 살리신산페닐, 살리신산옥틸, 살리신산벤질, 살리신산부틸페닐, 살리신산호모멘틸, 계피산벤질, 파라메톡시계피산-2-에톡시에틸, 파라메톡시계피산옥틸, 디파라메톡시계피산모노-2-에틸헥산글리세릴, 파라메톡시계피산이소프로필, 디이소프로필ㆍ디이소프로필계피산에스테르 혼합물, 우로카닌산, 우로카닌산에틸, 히드록시메톡시벤조페논, 히드록시메톡시벤조페논술폰산 및 그 염, 디히드록시메톡시벤조페논, 디히드록시메톡시벤조페논디술폰산나트륨, 디히드록시벤조페논, 테트라히드록시벤조페논, 4-tert-부틸-4'-메톡시디벤조일메탄, 2,4,6-트리아닐리노-p-(카르보-2'-에틸헥실-1'-옥시)-1,3,5-트리아진, 2-(2-히드록시-5-메틸페닐)벤조트리아졸 등을 들 수 있다.Examples of the ultraviolet absorber include paraaminobenzoic acid, ethyl paraaminobenzoate, amyl paraaminobenzoic acid, octyl paraaminobenzoate, ethylene glycol salicylate, phenyl salicylate, octyl salicylate, benzyl salicylate, butylphenyl salicylate, homomentyl salicylic acid, and cinnamic acid. Benzyl, paramethoxy cinnamic acid-2-ethoxyethyl, paramethoxy cinnamic acid octyl, diparamethoxy cinnamic acid mono-2-ethylhexaneglyceryl, paramethoxy cinnamic acid isopropyl, diisopropyl diisopropyl cinnamic acid ester mixture, Urocanoic acid, ethyl urocanate, hydroxymethoxybenzophenone, hydroxymethoxybenzophenonesulfonic acid and salts thereof, dihydroxymethoxybenzophenone, dihydroxymethoxybenzophenonedisulfonic acid sodium salt, dihydroxybenzo Phenone, tetrahydroxybenzophenone, 4-tert-butyl-4'-methoxydibenzoylmethane, 2,4,6-trianilino-p- (carbo-2'-ethylhexyl-1'-oxy)- 1,3,5-triazine, 2- (2-hydroxy -5-methylphenyl) benzotriazole etc. are mentioned.
살균제로는 히노키티올, 트리클로산, 트리클로로히드록시디페닐에테르, 크로르헥시딘글루콘산염, 페녹시에탄올, 레조르신, 이소프로필메틸페놀, 아줄렌, 살리칠산, 진크필리티온, 염화벤잘코늄, 감광소 301호, 모노니트로과이어콜나트륨, 운데시렌산 등을 들 수 있다.The fungicides include hinokithiol, trichloric acid, trichlorohydroxydiphenyl ether, chlorhexidine gluconate, phenoxyethanol, resorcin, isopropylmethylphenol, azulene, salicylic acid, zinphylthione, benzalkonium chloride, Photosensitizer 301, mononitrourecosodium, undecylenic acid, and the like.
산화 방지제로는 부틸히드록시아니솔, 갈릭산프로필, 엘리소르빈산 등을 들 수 있다.Examples of the antioxidants include butylhydroxyanisole, propyl gallic acid, and erythorbic acid.
pH 조정제로는 시트르산, 시트르산나트륨, 말산, 말산나트륨, 프말산, 프말산나트륨, 숙신산, 숙신산나트륨, 수산화나트륨, 인산일수소나트륨 등을 들 수 있다.Examples of the pH adjuster include citric acid, sodium citrate, malic acid, sodium malate, fmaric acid, sodium pmarate, succinic acid, sodium succinate, sodium hydroxide, sodium dihydrogen phosphate, and the like.
알코올로는 세틸알코올 등의 고급 알코올을 들 수 있다.As alcohol, higher alcohols, such as cetyl alcohol, are mentioned.
또한, 이외에 첨가해도 되는 배합 성분은 이에 한정되는 것은 아니며, 상기 어느 성분도 본 발명의 목적 및 효과를 손상시키지 않는 범위 내에서 배합 가능하지만, 총 중량에 대하여 바람직하게는 0.01 내지 5 % 중량 백분율, 보다 바람직하게는 0.01 내지 3 % 중량 백분율로 배합된다.In addition, the compounding component which may be added other than this is not limited to this, Although any said component can be mix | blended within the range which does not impair the objective and effect of this invention, Preferably it is 0.01 to 5% weight percentage with respect to a total weight, More Preferably 0.01 to 3% by weight.
본 발명의 화장료 조성물은 용액, 유화물, 점성형 혼합물 등의 형상을 취할 수 있다.The cosmetic composition of the present invention may take the form of a solution, an emulsion, a viscous mixture, or the like.
본 발명의 화장료 조성물에 포함되는 성분은 유효성분으로서 상기 약재 추출물 이외에 화장료 조성물에 통상적으로 이용되는 성분들을 포함할 수 있으며, 예를 들면, 안정화제, 용해화제, 비타민, 안료 및 향료와 같은 통상적인 보조제 및 담체를 포함한다.Components included in the cosmetic composition of the present invention as an active ingredient may include components commonly used in cosmetic compositions in addition to the medicinal extract, for example, conventional stabilizers, solubilizers, vitamins, pigments and flavorings Adjuvants and carriers.
본 발명의 화장료 조성물은 당업계에서 통상적으로 제조되는 어떠한 제형으로도 제조될 수 있으며, 예를 들어 유액, 크림, 화장수, 팩, 파운데이션, 로션, 미용액, 모발화장료 등을 들 수 있다.The cosmetic composition of the present invention may be prepared in any formulation commonly prepared in the art, and includes, for example, milky lotion, cream, lotion, pack, foundation, lotion, essence, hair cosmetic, and the like.
본 발명의 제형이 페이스트, 크림 또는 겔인 경우에는 담체 성분으로서 동물섬유, 식물섬유, 왁스, 파라핀, 전분, 트라칸트, 셀룰로오스 유도체, 폴리에틸렌 글리콜, 실리콘, 벤토나이트, 실리카, 탈크 또는 산화아연 등이 이용될 수 있다.When the formulation of the present invention is a paste, cream or gel, animal carriers, vegetable fibers, waxes, paraffins, starches, tracantes, cellulose derivatives, polyethylene glycols, silicones, bentonites, silicas, talc or zinc oxide, etc. may be used as carrier components. Can be.
본 발명의 제형이 파우더 또는 스프레이인 경우에는 담체 성분으로서 락토스, 탈크, 실리카, 알루미늄 히드록시드, 칼슘 실리케이트 또는 폴리아미드 파우더가 이용될 수 있고, 특히 스프레이인 경우에는 추가적으로 클로로플루오로히드로카본, 프로판/부탄 또는 디메틸 에테르와 같은 추진체를 포함할 수 있다.When the formulation of the present invention is a powder or a spray, lactose, talc, silica, aluminum hydroxide, calcium silicate or polyamide powder may be used, in particular in the case of a spray, additionally chlorofluorohydrocarbon, propane Propellant such as butane or dimethyl ether.
본 발명의 제형이 용액 또는 유탁액의 경우에는 담체 성분으로서 용매, 용매화제 또는 유탁화제가 이용되고, 예컨대 물, 에탄올, 이소프로판올, 에틸 카보네이트, 에틸 아세테이트, 벤질 알코올, 벤질 벤조에이트, 프로필렌 글리콜, 1,3-부틸글리콜 오일, 글리세롤 지방족 에스테르, 폴리에틸렌 글리콜 또는 소르비탄의 지방산 에스테르가 있다.When the formulation of the present invention is a solution or emulsion, a solvent, solvating or emulsifying agent is used as the carrier component, such as water, ethanol, isopropanol, ethyl carbonate, ethyl acetate, benzyl alcohol, benzyl benzoate, propylene glycol, 1 Fatty acid esters of, 3-butylglycol oil, glycerol aliphatic ester, polyethylene glycol or sorbitan.
본 발명의 제형이 현탁액인 경우에는 담체 성분으로서 물, 에탄올 또는 프로필렌 글리콜과 같은 액상 희석제, 에톡실화 이소스테아릴 알코올, 폴리옥시에틸렌 소르비톨 에스테르 및 폴리옥시에틸렌 소르비탄 에스테르와 같은 현탁제, 미소결정성 셀룰로오스, 알루미늄 메타히드록시드, 벤토나이트, 아가 또는 트라칸트 등이 이용될 수 있다.When the dosage form of the present invention is a suspension, liquid carrier diluents such as water, ethanol or propylene glycol, suspending agents such as ethoxylated isostearyl alcohol, polyoxyethylene sorbitol ester and polyoxyethylene sorbitan ester, microcrystalline Cellulose, aluminum metahydroxy, bentonite, agar or tracant and the like can be used.
본 발명의 제형이 계면-활성제 함유 클린징인 경우에는 담체 성분으로서 지방족 알코올 설페이트, 지방족 알코올 에테르 설페이트, 설포숙신산 모노에스테르, 이세티오네이트, 이미다졸리늄 유도체, 메틸타우레이트, 사르코시네이트, 지방산 아미드 에테르 설페이트, 알킬아미도베타인, 지방족 알코올, 지방산 글리세리드, 지방산 디에탄올아미드, 식물성 유, 리놀린 유도체 또는 에톡실화 글리세롤 지방산 에스테르 등이 이용될 수 있다.When the formulation of the present invention is a surfactant-containing cleansing, the carrier component is an aliphatic alcohol sulfate, an aliphatic alcohol ether sulfate, a sulfosuccinic acid monoester, an isethionate, an imidazolinium derivative, a methyltaurate, a sarcosinate, a fatty acid amide. Ether sulfates, alkylamidobetaines, aliphatic alcohols, fatty acid glycerides, fatty acid diethanolamides, vegetable oils, linolin derivatives or ethoxylated glycerol fatty acid esters and the like can be used.
본 발명의 화장료 조성물은 헤어토닉, 헤어컨디셔너, 헤어에센스, 헤어로션, 헤어영양로션, 헤어샴푸, 헤어린스, 헤어트리트먼트, 헤어크림, 헤어영양크림, 헤어모이스처크림, 헤어맛사지크림, 헤어왁스, 헤어 에어로졸, 헤어팩, 헤어영양팩, 헤어비누, 헤어클렌징폼, 머릿기름, 모발건조제, 모발보존처리제, 모발염색제, 모발용 웨이브제, 모발탈색제, 헤어겔, 헤어글레이즈, 헤어드레싱어, 헤어래커, 헤어모이스처라이저, 헤어무스 또는 헤어스프레이 등과 같은 화장품류로 제조될 수 있으나, 이에 제한되는 것은 아니다.The cosmetic composition of the present invention is a hair tonic, hair conditioner, hair essence, hair lotion, hair nutrition lotion, hair shampoo, hair rinse, hair treatment, hair cream, hair nourishment cream, hair moisturizer cream, hair massage cream, hair wax, Hair aerosol, hair pack, hair nutrition pack, hair soap, hair cleansing foam, hair oil, hair drier, hair preservative, hair dye, hair wave agent, hair bleach, hair gel, hair glaze, hair dresser, hair lacquer, hair moisturizer It may be prepared as a cosmetic, such as a riser, hair mousse or hair spray, but is not limited thereto.
본 발명의 의약 조성물은 O자형 탈모, M자형 탈모, OM복합 탈모, 옆머리 탈모, 유전성 탈모 등인 남성형 탈모, 정수리 부위의 모발이 가늘어지고 적어지는 확산형 탈모 등인 여성형 탈모, 원형 탈모에 사용될 수 있는 등 다양한 탈모 증상에 사용될 수 있다.The pharmaceutical composition of the present invention can be used for female hair loss, circular hair loss, such as O-shaped hair loss, M-shaped hair loss, OM complex hair loss, lateral hair loss, hereditary hair loss, male hair loss, diffuse hair loss in which the hair at the crown area becomes thinner and thinner, and the like. It can be used for various hair loss symptoms.
이하, 본 발명을 구체적으로 설명하기 위해 실시예를 들어 상세하게 설명하기로 하였다.Hereinafter, the present invention will be described in detail with reference to Examples.
실시예Example
In vitro 실험In vitro experiment
1. 실험 재료1. Experimental Materials
에탄올 30% 15 ml에 어성초 1 g을 넣고 86℃로 3시간 추출하고, 여과 농축 및 열풍건조 또는 분무건조하여 어성초 추출물을 제조하였다.1 g of edible vinegar was added to 15 ml of ethanol 30%, extracted at 86 ° C. for 3 hours, and concentrated by filtration, hot air drying or spray drying to prepare a eosung vinegar extract.
에탄올 30% 15 ml에 자소엽 1 g을 넣고 86℃로 3시간 추출하고, 여과 농축 및 열풍건조 또는 분무건조하여 자소엽 추출물을 제조하였다.1 g of leaflets in 15 ml of ethanol was extracted and extracted at 86 ° C. for 3 hours, filtered and concentrated by hot air drying or spray drying to prepare a leaf extract.
에탄올 30% 15 ml에 녹차 1 g을 넣고 86℃로 3시간 추출하고, 여과 농축 및 열풍건조 또는 분무건조하여 녹차 추출물을 제조하였다.1 g of green tea was added to 15 ml of ethanol 30%, extracted at 86 ° C. for 3 hours, and concentrated by filtration, hot air drying or spray drying to prepare green tea extract.
상기 추출물을 하기 표 1에 기재된 함량비로 혼합하였다(추출 후 혼합).The extract was mixed in the content ratio shown in Table 1 (mixed after extraction).
또한, 하기 표 2의 실시예 5 내지 10을 만들어 발효여부에 따른 효과와 추출방법에 따른 효과를 실시예의 효과와 비교하였다.In addition, Examples 5 to 10 of Table 2 were made to compare the effects of the effect of the fermentation and extraction method and the effect of the Example.
실시예 5의 경우 에탄올 30% 15 ml에 어성초 1 g, 자소엽 1 g, 녹차 1 g을 각각 86℃로 3시간 추출한 후 15 내지 25℃의 온도 조건 및 50 내지 60%의 상대습도 조건에서 3개월간 발효하고, 여과 농축 및 열풍건조 또는 분무건조 추출물을 혼합하여 제조하였다.In Example 5, after extracting 1 g of eosungcho, 1 g of Japonica leaf, and 1 g of green tea at 86 ° C. for 3 hours in 15 ml of ethanol 30%, the mixture was dried at 3 ° C. at 15-25 ° C. and 50-60% relative humidity. It was fermented for months and prepared by mixing filtration concentrated and hot air dried or spray dried extracts.
실시예 6의 경우 에탄올 30% 60 ml에 성초 2 g, 자소엽 1 g, 녹차 1 g 를 혼합 한 후 86℃로 3시간 추출하고, 여과 농축 및 열풍건조 또는 분무건조하여 추출물을 제조하였다. In the case of Example 6, 2 g of vinegar, 1 g of ginseng leaf, 1 g of green tea were mixed with 60 ml of ethanol 30%, extracted at 86 ° C. for 3 hours, filtered, concentrated, hot air dried or spray dried to prepare an extract.
실시예 7의 경우 에탄올 30% 60 ml에 어성초 2 g, 자소엽 1 g, 녹차 1 g 를 혼합 한 후 86℃로 3시간 추출 후 15 내지 25℃의 온도 조건 및 50 내지 60%의 상대습도 조건에서 3개월간 발효하고, 여과 농축 및 열풍건조 또는 분무건조 추출물을 혼합하여 제조하였다.In the case of Example 7, 2 g of Eoseongcho, 1 g of Japonica and 1 g of green tea were mixed in 60 ml of ethanol 30%, and extracted at 86 ° C. for 3 hours, followed by temperature conditions of 15 to 25 ° C. and relative humidity of 50 to 60%. Fermented for 3 months in, filtered concentrated and hot air dried Or spray dried extract was prepared by mixing.
실시예 8의 경우 에탄올 30% 15 ml에 어성초 1 g, 자소엽 1 g, 녹차 1 g을 각각 86℃로 3시간 추출한 후 15 내지 25℃의 온도 조건 및 50 내지 60%의 상대습도 조건에서 3개월간 발효하고, 여과 농축 및 열풍건조 또는 분무건조 추출물을 혼합하여 제조하였다.In Example 8, after extracting 1 g of eosungcho, 1 g of ginseng leaf, and 1 g of green tea at 86 ° C. for 3 hours in 15 ml of ethanol 30%, 3 at 15-25 ° C. and 50-60% relative humidity conditions It was fermented for months and prepared by mixing filtration concentrated and hot air dried or spray dried extracts.
실시예 9의 경우 에탄올 30% 60 ml에 어성초 2 g, 자소엽 1 g, 녹차 1 g 를 혼합 한 후 86℃로 3시간 추출하고, 여과 농축 및 열풍건조 또는 분무건조하여 추출물을 제조하였다.In the case of Example 9, 2 g of Echoseongcho, 1 g of Japonica, and 1 g of green tea were mixed in 60 ml of ethanol 30%, extracted at 86 ° C. for 3 hours, filtered, concentrated and hot air dried or spray dried to prepare an extract.
실시예 10의 경우 에탄올 30% 60 ml에 어성초 2 g, 자소엽 1 g, 녹차 1 g 를 혼합 한 후 86℃로 3시간 추출 후 15 내지 25℃의 온도 조건 및 50 내지 60%의 상대습도 조건에서 3개월간 발효하고, 여과 농축 및 열풍건조 또는 분무건조 추출물을 혼합하여 제조하였다.In the case of Example 10, 2 g of Echochocho, 1 g of Japonica, and 1 g of green tea were mixed in 60 ml of ethanol 30%, and extracted at 86 ° C. for 3 hours, followed by temperature conditions of 15 to 25 ° C. and relative humidity of 50 to 60%. It was fermented for 3 months in, prepared by mixing filtration concentrated and hot air dried or spray dried extract.
2. 2. BrdUBrdU assay assay
(1) 실험 원리(1) experimental principle
Halogenated nucleotides such as the pyrimidine analog bromodeoxyuridine (BrdU) 는 살아있는 세포 혹은 조직의 nascent (초기) DNA를 염색하는데 유용하다. 세포 주기 중 핵 내 DNA가 복제되어 DNA량이 두 배가 되는 시기인 "S"기 에서 BrdU는 복제 중인 DNA의 티미딘 대신에 BrdU가 사용되며, 이를 BrdU 항체를 이용한 염색을 통해서 합성된 DNA 양을 확인할 수 있다.Halogenated nucleotides such as the pyrimidine analog bromodeoxyuridine (BrdU) are useful for staining nascent (early) DNA in living cells or tissues. BrdU is used instead of thymidine in the replicating DNA in the "S" phase, when DNA in the nucleus is doubled in the cell cycle, and the amount of synthesized DNA is confirmed by staining with BrdU antibody. Can be.
(2) 실험 방법(2) Experiment method
1) cell pellet이 있는 tube에 culture medium 1ml을 넣어 suspension하였다.1) Culture medium 1ml into the tube containing the cell pellet was suspended.
2) Haemacytometer (혈구측정기)에 10㎕ 넣어서 현미경으로 cell 수를 관찰하였다.2) 10μl into the Haemacytometer (hemocytometer) and observed the number of cells under a microscope.
3) 실험을 위해 96 well에 1ㅧ 10⁴세포를 seeding 하였다. 이때 well 당 media는 100㎕씩 넣었다. seeding 후 37℃ CO2 incubator안에서 well을 보관하였다.3) 1 ㅧ 10 ㅧ cells were seeded into 96 wells for the experiment. At this time, 100 μl of media was added per well. After seeding, wells were stored in a 37 ° C. CO 2 incubator.
4) 37℃ CO2 incubator에서 24시간 보관 후, 실시예 및 비교예의 조성에 따라 처리하고, 37℃ CO2 incubator안에서 보관하였다.4) After storage for 24 hours in a 37 ℃ CO 2 incubator, it was treated according to the compositions of Examples and Comparative Examples, and stored in 37 ℃ CO 2 incubator.
5) 37℃ CO2 incubator에서 24시간 보관 후 10X BrdU solution을 10㎕ 넣고 1시간 동안 incubation을 한 다음 medium을 제거하였다.5) After 24 hours storage at 37 ℃ CO 2 incubator 10μl 10X BrdU solution was added and incubation for 1 hour and then the medium was removed.
6) Fixing/ Denaturing solution 100㎕ 넣고 상온에서 30분 둔 후에 Solution을 제거하고 1X Dectection antibody solution을 100㎕ 넣고 상온에서 1시간 두었다.6) Add 100µl of Fixing / Denaturing solution, leave at room temperature for 30 minutes, remove the solution, add 100µl of 1X Dectection antibody solution, and leave at room temperature for 1 hour.
7) Washing buffer로 3번 세척하였다.7) washed three times with Washing buffer.
8) 1X HRP-conjugated secondary antibody solution을 well 당 100㎕로 처리한 후 상온에서 30분간 두었다.8) Treated with 1X HRP-conjugated secondary antibody solution at 100 μl per well and left for 30 minutes at room temperature.
9) Washing buffer로 3번 세척하였다.9) washed three times with Washing buffer.
10) TMB Substrate를 각 well에 100㎕씩 넣고, 상온에서 30분동안 보관한 후, STOP solution을 각 well에 100㎕씩 넣어주었다.10) 100 μl of TMB Substrate was added to each well, stored at room temperature for 30 minutes, and then 100 μl of STOP solution was added to each well.
11) ELISA reader를 사용하여 wave length 450nm에서 각 well의 흡광도를 측정하였다.11) The absorbance of each well was measured at a wave length of 450 nm using an ELISA reader.
(3) 실험 결과(3) experimental results
표 3은 실시예의 처리 농도에 따른 흡광도 값을 나타낸 것으로, 흡광도가 높을수록 탈모 예방, 개선 또는 치료 효과가 우수한 것을 의미한다.Table 3 shows the absorbance value according to the treatment concentration of the embodiment, the higher the absorbance means that the better the hair loss prevention, improvement or treatment effect.
3. 3. MTTMTT assay assay
(1) 실험 원리(1) experimental principle
세포의 증식 또는 살아있는 세포를 정확하게 측정할 수 있는 기법으로 MTT assay는 colorimetric assay로써 색 변화를 통해 특정파장의 흡광을 재는 실험방법이다. 탈수소효소 작용에 의하여 노란색의 수용성 기질인 MTT tetrazolium을 보라색을 띄는 비 수용성의 MTT formazan(3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl-tetrazolium bromide)으로 환원시키는 미토콘드리아의 능력을 이용하는 검사법이다. 흡광도가 높게 나올수록 살아있는 세포의 수가 많은 것이고, 적을수록 죽은 세포가 많다고 볼 수 있다. As a technique to accurately measure the proliferation of cells or living cells, the MTT assay is a colorimetric assay that measures the absorption of a specific wavelength through color change. By dehydrogenase action, mitochondria reduce yellow soluble MTT tetrazolium to purple non-soluble MTT formazan (3- (4,5-dimethylthiazol-2-yl) -2,5-diphenyl-tetrazolium bromide). A test that uses abilities. The higher the absorbance, the greater the number of living cells, and the lower the number of dead cells.
(2) 실험 방법(2) Experiment method
1) 1ml pipette을 사용하여 culture medium 1ml을 cell pellet이 있는 15-ml tube에 넣고 tappin하였다.1) Using a 1ml pipette, 1 ml of culture medium was placed in a 15-ml tube with cell pellet and tappin.
2) Haemacytometer(혈구측정기)에 10㎕ 넣어서 현미경으로 cell 수 관찰하였다.2) 10μl into a Haemacytometer (hemocytometer) and observed the number of cells under a microscope.
3) MTT 실험을 위해 96well에 1ㅧ 10⁴세포를 seeding 하였다. 이때 well 당 media는 100㎕씩 넣어주었다.3) 1 ㅧ 10⁴ cells were seeded into 96well for MTT experiment. At this time, 100 μl of media was added per well.
4) 세포를 seeding 후 37℃ CO2 incubator안에서 보관하였다.4) Cells were seeded and stored in a 37 ° C. CO 2 incubator.
5) CO2 incubator에서 24시간 보관 후 실시예 및 비교예의 조성에 따라 처리하고, 37℃ CO2 incubator안에서 보관하였다.5) After 24 hours storage in a CO 2 incubator and treated according to the compositions of Examples and Comparative Examples, it was stored in 37 ℃ CO 2 incubator.
6) CO2 incubator에서 24시간 보관 후 media suction기를 이용하여 well에서 media 제거하였다.6) After 24 hours of storage in a CO 2 incubator, media was removed from the well using a media suction.
7) well 당 DPBS 100㎕씩 넣고 washing하였다.7) Put 100µl of DPBS per well and wash.
8) culture medium 90㎕에 MTT solution 10㎕를 희석시킨 용액을 well 수만큼 만들고, 각 well에 100㎕씩 넣었다.8) Prepare a solution of 10 μl of MTT solution in 90 μl of culture medium, and add 100 μl to each well.
9) 30분에서 최대 4시간까지 37℃ CO2 incubator안에서 보관하였다. (각 실험은 동일한 incubator를 사용하였다.)9) Stored in a 37 ° C. CO 2 incubator for 30 minutes up to 4 hours. (Each experiment used the same incubator.)
10) ELISA reader를 사용하여 450nm의 파장에서 흡광도를 측정하였다.10) Absorbance was measured at a wavelength of 450 nm using an ELISA reader.
(3) 실험 결과(3) experimental results
표 4는 실시예의 처리 농도에 따른 흡광도 값을 나타낸 것으로, 흡광도가 높을수록 탈모 예방, 개선 또는 치료 효과가 우수한 것을 의미한다.Table 4 shows the absorbance value according to the treatment concentration of the embodiment, the higher the absorbance means that the better the hair loss prevention, improvement or treatment effect.
In In vivovivo 실험 Experiment
1. 동물실험 목적1. Purpose of animal experiment
탈모의 원인으로는 유전적, 스트레스, 노화 등이 있지만, Hamilton (1942)이 남성 호르몬과의 관계를 밝혀낸 이후 남성 호르몬의 분비가 원인이 되고 있는 것으로 알려져 있다. Dihydrotestosterone (DHT)이 모낭의 안드로겐 수용체와 결합하여 단백질 합성을 지연시켜 모낭의 성장기가 단축되고, 해당 모낭은 성장기가 빨리 끝나고 휴지기로 들어가게 되어 휴지기 모낭의 비율이 증가되며 이러한 과정이 반복되면서 모발은 점차 가늘고 짧게 되어 발생한다. 모근 세포내에 존재하는 5-α-reductase는 남성 호르몬인 testosterone을 더욱 강력한 대사체인 DHT로 전환 되도록 하는 효소로서 호르몬 활성도가 보통의 testosterone보다 약 10배나 강하며 모근에 작용하여 모발의 발육을 억제한다.The causes of hair loss include heredity, stress, and aging, but since Hamilton (1942) discovered a relationship with testosterone, it is known that testosterone secretion is the cause. Dihydrotestosterone (DHT) binds to androgen receptors in hair follicles, delaying protein synthesis and shortening hair follicle growth phases, and the hair follicles quickly end and enter the resting phase, which increases the proportion of resting hair follicles. It occurs because it is thin and short. 5-α-reductase in hair follicle cells is an enzyme that converts testosterone, a testosterone, into DHT, a more powerful metabolite, and has about 10 times stronger hormone activity than normal testosterone and acts on the hair roots to inhibit hair growth.
남성 호르몬과의 관계를 밝혀낸 이후 남성 호르몬과 관련된 연구가 많이 이루어지고 있지만, 아직까지 탈모의 원인이나 기전이 명확하게 밝혀진 것은 아니다. 현재 개발되어 상용화된 제품은 두피에 이상이 생기는 등의 부작용이 발생하는 문제점이 있다.After discovering the relationship with testosterone, a lot of research has been done on testosterone, but the cause or mechanism of hair loss is not yet clear. Currently developed and commercialized products have problems such as side effects such as abnormalities in the scalp.
이에, 위와 같은 문제점을 해결하면서 탈모 예방, 치료 또는 개선의 효과를 나타낼 수 있는 천연 약재를 포함하는 본 발명의 생체 내 효과를 규명하기 위해 본 실험을 실시하였다.Thus, this experiment was conducted to identify the in vivo effects of the present invention, including natural medicines that can exhibit the effect of preventing, treating or improving hair loss while solving the above problems.
2. 실험 방법2. Experimental method
(1) 동물실험(1) animal experiment
생후 6주 된 수컷 C57BL/6 mouse를 구입하여 온도 24℃±0.5℃, 습도 55±5% 및 12시간 주기로 명암이 자동으로 조절되는 사육 조건 하에서 실험동물용 사료를 자유로이 급여하며 관리하였다.Six-week-old male C57BL / 6 mice were purchased and administered freely to feed for experimental animals under rearing conditions in which the contrast was automatically controlled at a temperature of 24 ° C ± 0.5 ° C, 55 ± 5% humidity, and 12-hour cycles.
C57BL/6 마우스는 생후 6 내지 7주령이 되면 대부분의 털이 모두 휴지기가 되며 피부색은 분홍색이 된다. 약 7일간 환경에 적응시킨 후 실험에 사용하였다.C57BL / 6 mice are 6-7 weeks old and most of the hair is at rest and the skin color is pink. After adapting to the environment for about 7 days, it was used for the experiment.
복강주사를 통한 마취하에 이발기를 이용하여 피부에 손상이 가지 않게 주의하여 마우스 등 부위의 털을 제거하고, 실험동물을 무작위로 폴리카보네이트 사육장에 분류하여 군을 나누었다.Under the anesthesia through intraperitoneal injection, the hair was removed by using a hair clipper to prevent damage to the skin, and the animals were randomly divided into polycarbonate kennels and divided into groups.
각 군당 정해진 천연물 복합체를 용량대로 4주간 경구 투여하였다.The defined natural product complexes in each group were administered orally for 4 weeks as doses.
양성 비교예는 경구용 finasteride를 0.5mg/day로 투여하였다 (Hui-Wen Chiu et al. 2013). 경구 투여는 식도 (혹은 기도)에 침습적인 방법으로 염증 및 손상이 우려되므로 숙련된 연구자가 시행하였다. 모든 동물실험은 본 성의교정 동물실험윤리위원회의 지침에 따라 진행한다(2015-0198-01). 각 군별 세부 내용은 다음과 같다.In the positive comparative example, oral finasteride was administered at 0.5 mg / day (Hui-Wen Chiu et al. 2013). Oral administration was performed by a skilled investigator because of concerns about inflammation and damage in a way that is invasive to the esophagus (or airway). All animal experiments should be conducted in accordance with the guidelines of the Orthodontic Animal Experimentation Ethics Committee (2015-0198-01). Details of each group are as follows.
1) 정상쥐 (n=3)1) normal rat (n = 3)
2) vehicle-negative control (n=3)2) vehicle-negative control (n = 3)
3) finasteride-positive control (n=3)3) finasteride-positive control (n = 3)
4) 실시예 3 200mg/kg (n=4)4) Example 3 200 mg / kg (n = 4)
5) 실시예 3 400mg/kg (n=4)5) Example 3 400 mg / kg (n = 4)
(2) 육안적 관찰(2) visual observation
실험 시작 후 모발의 상태를 육안적으로 확인하기 위하여 디지털 카메라를 이용하여 사진 촬영을 실시한다. 시작 시기, 1주, 2주 및 3주 후의 사진 및 등 부위의 모발상태에 따라서 0 내지 4까지 등급을 정하여 표기하여 각 군별로 비교한다.In order to visually check the condition of the hair after the start of the experiment, take a picture using a digital camera. According to the start time, 1 week, 2 weeks, and 3 weeks after the photograph and the hair condition of the back region, the grades of 0 to 4 are designated and compared.
0: 0% 내지 20%의 털이 재생된 경우0: when 0% to 20% of hair is regenerated
1: 20% 내지 40%의 털이 재생된 경우1: 20% to 40% hair regeneration
2: 40% 내지 60%의 털이 재생된 경우2: 40% to 60% hair regeneration
3: 60% 내지 80%의 털이 재생된 경우3: 60% to 80% hair regeneration
4: 80% 내지 100%의 털이 재생된 경우4: 80% to 100% hair regenerated
(3) 조직학적 검사(3) histological examination
실험시작 4주 후에 모든 실험동물을 희생하고 피부를 적출하여 10% 포르말린에 즉시 고정한다. 고정된 조직은 알코올과 자일렌을 이용하여 탈수 시킨 후 파라핀에 포매하고 두께 4μm의 절편을 제작해 헤마톡실린-에오진(Hematoxylin-Eosin) 염색을 하여 현미경상에서 조직학적 변화를 관찰한다. Four weeks after the start of the experiment, all animals were sacrificed and the skin was removed and immediately fixed in 10% formalin. The immobilized tissues were dehydrated with alcohol and xylene, embedded in paraffin, and 4 μm thick sections were prepared and stained with hematoxylin-eosin to observe histological changes under a microscope.
(4) 모발성장인자로 알려진 IGF -1과 모발성장억제 및 탈모 유발인자인 TGF -β1의 발현 (4) Expression of IGF- 1 , known as hair growth factor, and TGF - β1 , a hair growth inhibitory and hair loss-inducing factor
조직 속에 함유되어 있는 Insulin-like growth factor (IGF-1), TGF- β1를 분석하기 위하여 -80℃에 보관하고 있던 등 피부조직 50mg에 lysis buffer (50 mM Tris-HCl, 120 mM NaCl, 2 nM EDTA, 1 mM EGTA, 1% Triton X-100) 200ul를 가하고 Homogenizer (Tissue tearor, Biospec, Korea)를 이용하여 분쇄하고 원심 분리 후 Lowly법을 이용하여 단백질을 정량한다. 50ug의 protein을 15% SDS-PAGE gel에 전기영동하고 PVDF paper로 이동시킨 다음, 5% skim milk로 1시간 동안 blocking하고, primary antibody (IGF-1, TGF-β1, abcam, Cambridge, UK)는 5% skim milk에 각각 1:1000로 희석하여 4℃에서 overnight하였다. 이후 1X PBST로 세척 후 secondary antibody (Goat anti-Rabbit IgG)를 5% skim milk에 1:1000으로 희석하여 1시간 동안 반응시킨 후 세척하고, ECL solution (Amersham, Arlington height, IL, USA)을 이용하여 이미지 분석기 (Image Analiyzer system, Syngene, UK)로 분석한다.In 50 mg of skin tissue such as Insulin-like growth factor (IGF-1) and TGF-β1 contained in the tissue, stored at -80 ° C, lysis buffer (50 mM Tris-HCl, 120 mM NaCl, 2 nM EDTA, 1 mM EGTA, 1% Triton X-100) 200ul was added, pulverized using a Homogenizer (Tissue tearor, Biospec, Korea), centrifuged, and the protein was quantified using Lowly method. 50 ug of protein was electrophoresed on a 15% SDS-PAGE gel, transferred to PVDF paper, blocked with 5% skim milk for 1 hour, and the primary antibody (IGF-1, TGF-β1, abcam, Cambridge, UK) The solution was diluted 1: 1000 in 5% skim milk and overnight at 4 ° C. After washing with 1X PBST, secondary antibody (Goat anti-Rabbit IgG) was diluted 1: 1000 in 5% skim milk and reacted for 1 hour, followed by washing, using ECL solution (Amersham, Arlington height, IL, USA). Analyze with an image analyzer (Image Analiyzer system, Syngene, UK).
3. 결과3. Results
(1) 육안적 관찰(1) visual observation
제모 1일후부터 프로스카와 시험물질을 경구 투여를 하였다. 모든 실험 군에서 투여 후 5일까지 거의 털이 자라지 않았다. 양성비교예와 시험물질군은 15일 이후로 음성비교예에 비해 더 많이 털이 자라기 시작하였고, 25일 이후에는 음성비교예 그룹을 제외한 그룹에서 전반적으로 모발이 검게 피부를 메우며 자라났다. 표 5는 육안으로 관찰하여 매긴 각 군별 등급을 나타낸 것이다.Prosca and test substance were orally administered 1 day after hair removal. Almost no hair grew until 5 days after administration in all experimental groups. The positive and test substance groups began to grow more hair than the negative comparisons after 15 days, and after 25 days, the hairs grew black and black in the groups except negative comparison groups. Table 5 shows the grades of each group which were observed by the naked eye.
(2) (2) HematoxylinHematoxylin and Eosin (H&E) and Eosin (H & E)
시험물질이 모발성장에 영향을 미치는 효과를 조사하기 위하여 물질을 경구 투여한 후 부검하여 모발성장 효과를 조직학적으로 관찰하였다.In order to investigate the effect of the test substance on the hair growth, the oral administration of the substance was followed by autopsy to observe the hair growth effect histologically.
음성비교예 (Negative control)에서 모발은 휴지기 상태를 유지하고 있는 반면, 양성비교예 (Positive control)과 시험물질군 (실시예 3 200mg/kg 및 400mg/kg)은 모낭의 수와 크기가 많이 증가하였다. 정상군은 성장기, 음성비교예는 휴지기를 유지하고 있으며, 양성비교예는 성장기로 모낭의 성장을 유도하고, 실시예 3 200mg/kg 군은 성장기로 모낭의 성장을 증진시키는 것으로 보여지며, 실시예 3 400mg/kg 군도 성장기에서 모낭의 빠른 성장과 모발의 재성장의 시간을 단축시키는 것으로 보여진다.In negative control, hair remained at rest, while positive control and test substance groups (Example 3 200mg / kg and 400mg / kg) increased the number and size of hair follicles significantly. It was. Normal group, growth phase, negative comparisons are at rest, positive comparisons induce hair follicle growth in growth phase, Example 3 200mg / kg group is shown to promote hair follicle growth in growth phase, Example 3 The 400 mg / kg group has also been shown to shorten the time for rapid hair follicle growth and hair regrowth in the growing phase.
시험물질은 용량별 차이도 있으며 모낭의 성장을 증진, 촉진시키고 발모에 도움을 주는 것으로 보여진다.Test substances vary in dosage and appear to promote, promote hair growth and help hair growth.
(3) (3) IGFIGF -1, -One, TGFTGF -- β1β1 Western blot analysis Western blot analysis
모발성장인자인 IGF-1, 모발성장억제 및 탈모유발인자인 TGF-β1 발현을 비교한 결과 IGF-1은 음성비교예에 비해 양성비교예에서 발현이 높았으며, 실시예 3 400mg/kg 군이 실시예 3 200mg/kg 군보다 모발성장인자가 과발현 되는 것으로 확인 되었다.The expression of IGF-1, hair growth inhibitory, and TGF-β1, a hair loss-inducing factor, was higher in the positive comparison than in the negative comparison. Example 3 400 mg / kg Example 3 It was confirmed that the hair growth factor is overexpressed than the 200mg / kg group.
탈모 유발인자인 TGF-β1은 음성비교예가 양성비교예에 비해 과발현 되는 것으로 나타났으며 실시예 3 400mg/kg 군이 실시예 3 200mg/kg 군보다 TGF-β1이 낮게 발현되는 것으로 확인 되었다.TGF-β1, a hair loss-inducing factor, was shown to be overexpressed in the negative comparison compared to the positive comparison, and Example 3 400mg / kg group was found to be lower TGF-β1 than Example 3 200mg / kg group.
4. 결론4. Conclusion
이번 실험에서 어성초, 자소엽 및 녹차를 이용한 천연물 복합체를 경구 투여하여 모발 성장 효능을 육안적, 조직학적 발모 효과를 확인 하였다. C57BL/6 마우스는 육모 모델로 체모가 검은색이고 조직학적이나 면역학적으로 사람의 조건과 매우 비슷하여 탈모증의 연구에 많이 사용되는 동물이다. 생후 7주령의 수컷 C57BL/6 사용해, 제모 후 휴지기 상태를 확인 한 후 실험을 시작하였다. 4주간 증류수, positive control-프로스카, 실시예 3 200mg/kg 또는 실시예 3 400mg/kg를 경구 투여 한 후 육안으로 관찰한 결과, 양성비교예와 시험물질군 (실시예 3 200mg/kg 및 400mg/kg)은 15일 이후로 음성비교예에 비해 더 많이 털이 자라기 시작하였다. 25일 이후에는 음성비교예 그룹을 제외한 다른 그룹에서는 모발이 검게 피부를 전반적으로 메우며 자라났다. H&E 실험 결과 음성비교예는 휴지기를 유지하고 있으며, 양성비교예는 성장기로 모낭의 성장을 유도하였고, 실시예 3 200mg/kg 군은 성장기로 모낭의 성장을 증진시켰으며, 실시예 3 400mg/kg 군도 성장기에서 모낭의 빠른 성장과 모발의 재성장의 시간을 단축하였다.In this experiment, the oral administration of natural complex using Echochocho, Japonica and Green Tea confirmed the gross and histological effects of hair growth. C57BL / 6 mice are a hair growth model and are used for the study of alopecia because their hair is black and histologically and immunologically very similar to human conditions. The experiment was started after confirming the resting period after depilation using male C57BL / 6 7 weeks old. After four weeks of oral administration of distilled water, positive control prosca, Example 3 200 mg / kg or Example 3 400 mg / kg, the positive comparison and the test substance group (Example 3 200 mg / kg and 400 mg / kg) began to grow more hair after 15 days compared to the negative comparison. After the 25th day, the hair grew black and filled the skin in the other groups except the negative comparison group. As a result of the H & E experiment, the negative comparison maintained the resting period, the positive comparison induced hair follicle growth in the growth phase, and Example 3 200mg / kg group improved the hair follicle growth in the growth phase, Example 3 400mg / kg. In the archipelago, the hair follicle growth and hair regrowth were shortened.
시험물질 경구 투여 4주후 IGF-1, TGF-β1의 발현을 측정한 결과 IGF-1은 정상군에 비해 시험물질 실시예 3 400mg/kg 군에서 발현양이 증가하였으며, 음성비교예에서는 IGF-1 발현이 낮고 TGF-β1의 발현이 높았다.The expression of IGF-1 and TGF-β1 was measured 4 weeks after oral administration of test substance, and the expression level of IGF-1 was increased in 400 mg / kg of test substance Example 3 compared to the normal group, and IGF-1 in the negative comparison example. The expression was low and the expression of TGF-β1 was high.
Catagen, Teolgen 시기에서 많이 발현되는 TGF-β1은 음성비교예에서 가장 많이 발현되었으며, 시험물질군에서는 TGF-β1의 발현이 낮아졌고, 모발성장인자인 IGF-1의 발현이 증가한 것으로 보아 시험물질은 휴지기에서 성장기로 전환시키는 인자들을 유도하여 모발 성장을 촉진시키는 효과를 나타내는 것을 확인하였다.TGF-β1, which is frequently expressed in Catagen and Teolgen periods, was the most expressed in the negative comparison cases, and in the test substance group, the expression of TGF-β1 was lowered, and the expression of IGF-1, a hair growth factor, was increased. It was confirmed that the effect of promoting hair growth by inducing factors that switch from the resting phase to the growth phase.
시험물질인 실시예 3 200mg/kg과 실시예 3 400mg/kg은 용량에 따라 그 효과에 있어서 확연한 차이가 있으며, 실시예 3를 400mg/kg을 처리한 군에서 200mg/kg을 처리한 군보다 모낭의 수가 증가했고, 모낭의 깊이 또한 증가했음을 확인하였다. 위 결과에 따를 때, 본 발명에 따른 조성물은 모낭의 성장을 증진 및 촉진시키고 발모에 도움을 줄 수 있다.Example 3 200mg / kg and Example 3 400mg / kg as a test substance has a significant difference in the effect according to the dose, Example 3 in the group treated with 400mg / kg hair follicle than 200mg / kg treated group The number of cells increased and the depth of hair follicles also increased. According to the above results, the composition according to the present invention may promote and promote hair follicle growth and help hair growth.
Claims (12)
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| PCT/KR2016/011928 WO2018074640A1 (en) | 2016-10-21 | 2016-10-21 | Pharmaceutical composition, health functional food, and cosmetic composition for preventing or treating hair loss |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| PCT/KR2016/011928 WO2018074640A1 (en) | 2016-10-21 | 2016-10-21 | Pharmaceutical composition, health functional food, and cosmetic composition for preventing or treating hair loss |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| WO2018074640A1 true WO2018074640A1 (en) | 2018-04-26 |
Family
ID=62019465
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PCT/KR2016/011928 Ceased WO2018074640A1 (en) | 2016-10-21 | 2016-10-21 | Pharmaceutical composition, health functional food, and cosmetic composition for preventing or treating hair loss |
Country Status (1)
| Country | Link |
|---|---|
| WO (1) | WO2018074640A1 (en) |
Citations (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR20150128544A (en) * | 2014-05-09 | 2015-11-18 | 이명식 | Method of Manufacturing Hair Restorer and Hair Restorer Manufactured by the same Method |
| KR20160023149A (en) * | 2014-08-21 | 2016-03-03 | 허형남 | Composition comprising extract of herbal mixture for preventing alopecia or hair growth effect |
| KR20160042571A (en) * | 2014-10-10 | 2016-04-20 | 류진환 | Scalp care composition and method thereof |
| KR20160069217A (en) * | 2014-12-08 | 2016-06-16 | 하창현 | Hair improvement herbal food |
| KR20160069953A (en) * | 2014-12-09 | 2016-06-17 | (주)산엔들 | Herbal shampoo composition for promoting hair growth |
| KR20160109332A (en) * | 2015-03-11 | 2016-09-21 | 주식회사 진생사이언스 | A Composition comprising a processed combined herb extract consisting of heat processed ginseng, Houttuyniae Herba, Perilla leaf and Tea leaves as an active ingredient showing hair-growth stimulating activity and preventing activity from hair loss |
| KR20160109872A (en) * | 2015-03-13 | 2016-09-21 | 농업법인 주식회사 미산약초농장 | Manufacturing method of improvement material for hair growth and white hair preventive |
| KR101659316B1 (en) * | 2015-06-17 | 2016-09-23 | 영림영농조합법인 제주편백우드 | Composition for stimulating hair growth and preparation method thereof |
| KR20170036640A (en) * | 2015-09-23 | 2017-04-03 | 주식회사 케미메디 | Medical composition for preventing or treating of alopecia, health functional food and cosmetic composition |
-
2016
- 2016-10-21 WO PCT/KR2016/011928 patent/WO2018074640A1/en not_active Ceased
Patent Citations (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR20150128544A (en) * | 2014-05-09 | 2015-11-18 | 이명식 | Method of Manufacturing Hair Restorer and Hair Restorer Manufactured by the same Method |
| KR20160023149A (en) * | 2014-08-21 | 2016-03-03 | 허형남 | Composition comprising extract of herbal mixture for preventing alopecia or hair growth effect |
| KR20160042571A (en) * | 2014-10-10 | 2016-04-20 | 류진환 | Scalp care composition and method thereof |
| KR20160069217A (en) * | 2014-12-08 | 2016-06-16 | 하창현 | Hair improvement herbal food |
| KR20160069953A (en) * | 2014-12-09 | 2016-06-17 | (주)산엔들 | Herbal shampoo composition for promoting hair growth |
| KR20160109332A (en) * | 2015-03-11 | 2016-09-21 | 주식회사 진생사이언스 | A Composition comprising a processed combined herb extract consisting of heat processed ginseng, Houttuyniae Herba, Perilla leaf and Tea leaves as an active ingredient showing hair-growth stimulating activity and preventing activity from hair loss |
| KR20160109872A (en) * | 2015-03-13 | 2016-09-21 | 농업법인 주식회사 미산약초농장 | Manufacturing method of improvement material for hair growth and white hair preventive |
| KR101659316B1 (en) * | 2015-06-17 | 2016-09-23 | 영림영농조합법인 제주편백우드 | Composition for stimulating hair growth and preparation method thereof |
| KR20170036640A (en) * | 2015-09-23 | 2017-04-03 | 주식회사 케미메디 | Medical composition for preventing or treating of alopecia, health functional food and cosmetic composition |
Non-Patent Citations (1)
| Title |
|---|
| KEMIMEDI CO LTD.: "Mogadeuk Houttuynia cordata Thumb Pill", 31 March 2015 (2015-03-31) * |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| WO2021149880A1 (en) | Composition for preventing hair loss or promoting hair growth, comprising, as active ingredient, mixed extract of cucumber, eggplant and snail | |
| WO2022231294A1 (en) | Composition for preventing, alleviating, or treating skin pigmentation | |
| WO2018117725A1 (en) | Composition for preventing hair loss and promoting hair growth, comprising fermented marine animal products | |
| WO2010123184A1 (en) | Composition for preventing and treating alopecia disorder containing norgalanthamine compounds as an active ingredient | |
| WO2016117762A1 (en) | Composition containing gooseberry extract or glutathione | |
| WO2021215882A1 (en) | Composition for preventing hair loss or promoting hair growth comprising camellia pericarp extract as active ingredient | |
| WO2016093515A1 (en) | Composition for activating longevity gene | |
| WO2020218720A1 (en) | Composition for preventing or treating muscular disorders or improving muscular functions, containing leonurus japonicus extract or leonurine | |
| WO2015037855A1 (en) | A composition comprising an extract of combined herbs consisting of acanthopanax koreanum nakai and crinum asiaticum var. japonicum showing preventing activity of baldness and stimulating activity of hair growth | |
| WO2017014597A1 (en) | Cosmetic composition for improving skin whitening containing schisandra chinensis seed extract | |
| WO2016056781A1 (en) | Composition for hair loss prevention or hair growth stimulation comprising artemisia umbelliformis extract | |
| WO2014185610A1 (en) | Composition for preventing hair loss or promoting hair growth by containing bran extract as active ingredient | |
| WO2018080039A1 (en) | Composition for preventing hair loss or improving hair growth, containing yellow-colored soybean leaf extract | |
| WO2021080297A1 (en) | Composition containing evening primrose flower extract as active ingredient for preventing or treating obesity or metabolic syndromes induced thereby | |
| WO2015167240A1 (en) | Composition containing scutellaria alpina extract | |
| WO2024181725A1 (en) | Red centella asiatica fermented with monascus and use thereof | |
| WO2016056780A1 (en) | Composition for hair loss prevention or hair growth stimulation comprising scutellaria alpina extract | |
| WO2020138834A1 (en) | Composition for preventing or treating skin diseases comprising bridalwreath spirea | |
| WO2023022540A1 (en) | Composition for preventing hair loss or promoting hair growth comprising milk thistle flower extract as active ingredient | |
| WO2020218840A1 (en) | Composition for inhibiting hair loss or promoting hair growth containing plant extract removed of chlorophyll or pigment as active ingredient, and method for producing same | |
| WO2018074640A1 (en) | Pharmaceutical composition, health functional food, and cosmetic composition for preventing or treating hair loss | |
| WO2020032296A1 (en) | Functional composition | |
| KR20140016057A (en) | Composition for preventing hair loss or improving hair growth containing extract of sargassum sagamianum | |
| WO2013024960A1 (en) | Medical composition containing stauntonia hexaphylla extract | |
| WO2022164183A1 (en) | Composition for promoting hair growth comprising lactobacillus curvatus-derived extracellular vesicles as active ingredient |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| 121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 16919385 Country of ref document: EP Kind code of ref document: A1 |
|
| NENP | Non-entry into the national phase |
Ref country code: DE |
|
| 32PN | Ep: public notification in the ep bulletin as address of the adressee cannot be established |
Free format text: NOTING OF LOSS OF RIGHTS PURSUANT TO RULE 112(1) EPC (EPO FORM 1205A DATED 07.08.2019) |
|
| 122 | Ep: pct application non-entry in european phase |
Ref document number: 16919385 Country of ref document: EP Kind code of ref document: A1 |